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ABSTRACT 
The association between iron elevation and neurodegenerative diseases has been well 
proven by a wide range of clinical and experimental studies. Brain iron was found to 
accumulate with age and iron depositions are observed in the affected brain areas of 
Parkinson's, Huntington's and Alzheimer's diseases. Owing to its potent 
pro-oxidative properties, iron accumulation has been suspected a causative role in 
neurodegenerative diseases. To give insights into the relationship between iron 
accumulation and deterioration of cognitive function, we examined the effect of 
iron-overloading on hippocampal synaptic functions, in both acute and chronic 
conditions. 
In the first study, the effect of acutely increased extracellular ferric iron was 
elucidated with the use of ferric ammonium citrate (FAC). The field excitatory 
postsynaptic potentials (fEPSPs) at the hippocampal Schaffer collateral pathway 
were recorded by multi-channel field-potential recording system. Our data revealed a 
dose-dependent relationship of ferric iron in both basal synaptic transmission and 
long term potentiation (LTP). FAC at a high concentration (SOO i^M) significantly 
inhibited the basal synaptic transmission, while the lower concentrations (40)iM and 
0.3|iM) had no effect. The reduction of basal synaptic transmission by 500|iM FAC 
- V -
was not accompanied by a change in paired-pulse ratio, which points to a 
post-synaptic mechanism of inhibition. Furthermore, a pattern of decreasing LTP 
magnitude with increasing FAC concentrations was observed. In the presence of 
0.3|iM FAC, the degree of LTP was decreased slightly. A significant and a further 
reduction of LTP was elicited when the FAC concentration increased to 40|j.M, while 
complete abolishment of LTP was found at 500|iM FAC. However, the effect of 
ferric iron in the FAC experiments was confirmed by examining the effect of 
ammonium citrate dibasic (AC), which elicited impairment of LTP at the higher 
concentration but at a much lower extent compared with that of FAC. 
In the second study, we examined the effect of chronic iron-loading generated by 
subcutaneous injection of iron dextran in rats. The sets of dosages (high dose: 0.1 g 
and low dose: 0.01 g of iron) and treatment durations (short term: one week and long 
term: four weeks), were combined to create four different iron loading paradigms. 
Interestingly, the two high dose paradigms induced a substantial elevation (30-40%) 
of total iron in the hippocampus, an extent which is in line with that of 
neurodegenerative diseases. Also, consistent with the results of the acute study, the 
LTP of both the short and long term high iron treatment groups were significantly 
reduced. Interestingly, the LTP of both the two low dose groups were found to be 
•vi -
significantly enhanced with respect to the control. Furthermore, assessment of 
protein oxidation and ROS content revealed a significant elevation in oxidative stress 
in rats with high dose iron treatments. Therefore, the iron induced exacerbation of 
oxidative stress may serve as one of the possible mechanisms that confer the 
reduction of LTP in our high iron models. 
In summary, this study has revealed that both acute and chronic administration of 
relatively high level of iron induce impairment on long term synaptic plasticity, 
mechanism of which is most probably post-synaptic. Our findings provide the first 
set of electrophysiological data showing that iron can impair neuronal mechanisms 
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1. INTRODUCTION 
Iron is the most abundant trace metal in the brain, functioning in a broad range of 
cellular processes. Nevertheless, iron is notorious for its potent oxidative catalytic 
properties. In fact, dysregulation of iron has been implicated in cell aging and a wide 
variety of neurodegenerative diseases. The importance of iron in synaptic function is 
supported by its anterograde axonal transport towards the synaptic region (Curtis et 
al.，2001; Dwork et al.，1990)，which is a major site of initiation of diseases e.g. in 
the deposition of amyloid plaques in Alzheminer's disease (Bamham and Bush, 
2008). However, up to now, very little is known about how iron accumulation affects 
synaptic function and, more generally, brain function. 
1.1 Brain iron function and diseases 
1.1.1 Function of iron in the brain 
Iron is the most abundant transition metal within the brain as well as the entire body. 
Its importance in brain function can be implied by its differing quantity across discret 
brain regions. Iron fiinction as a cofactor for a number of enzymatic reactions. It is a 
crucial component in heme, iron-sulfiir clusters and various other proteins. Therefore, 
this essential element plays crucial roles in the various fundamental aspects of cell 
functions，e.g. oxygen transport, electron transport, energy metabolism in 
1 
mitochondria, protein synthesis, hormone production, nucleotide synthesis, cell 
differentiation, and detoxification etc. (Hentze and Kuhn, 1996; Jorgenson et al.， 
2003). The metabolic functions of iron are important for the brain to sustain its high 
respiratory requirement. On the other hand, iron is an essential prosthetic group of a 
number of neurotransmitter synthesizing enzymes (linger et al., 2007; Zecca et al., 
2004)，for instance, the tryptophan hydroxylase involved in serotonin production, the 
tyrosine hydroxylase responsible for norepinephrine and dopamine synthesis 
(Hasegawa et al.，1999; Lehmaim and Heinrich, 1986)，the glutamate decarboxylase 
and glutamate transaminase participate in Y-Aminobutyric acid and L-glutamate 
synthesis (Li, 1998; Shukla et al., 1989) and the monoamine oxidases A and B 
involved in dopamine catabolism (Green and Youdim, 1977; Yehuda et al., 2005). 
Furthermore, myelinogenesis, a process that is critical for synaptic sprouting and 
neuronal wiring, also requires iron (Beard et al., 2003; Moos and Morgan, 2004). 
Therefore, it is not surprising that an appropriate amount of iron is a requisite for 
normal nervous function. 
1.1.2 Iron involved oxidative damage 
Despite its functional importance, iron is notorious for its oxidative toxicity. The 
chemistry of iron's divalent state grants its potent pro-oxidative properties. Iron can 
2 
rapidly react with hydrogen peroxide and superoxide through the Fenton reaction. 
This iron-dependent reaction decomposes hydrogen peroxide to the highly reactive 
and thus toxic hydroxyl radical. More detrimentally, through the Haber-Weiss 
chemical reaction (see Figure. 1.1), a damaging cycle of hydroxyl radical generation 
is resulted (Papanikolaou and Pantopoulos, 2005). The resulting free radicals，at 
excessive level, would induce oxidative damage to cellular components, for example 
lipid peroxidation, DNA strand breakage, protein oxidation, and modification or 
degradation of other biomolecules (Galaris et al.，2008). These processes, not 
surprisingly, are suggested to participate in the neuronal loss in Alzheimer's disease 
(AD) (Gutteridge，1994; Smith et al, 1991). Mechanisms involved in iron induced 
oxidative cell damage with special reference to neurodegenerative diseases are 




Fe2+ + H2O2 Fe3+ + 0H" + .OH I 
Fe3+ + . ( V Fe2+ + O2 
Net Haber-Weiss reaction: 
Fe^ V Fe2+ 1 
•O2" + H2O2 + O2 + OH" + -OH 
Figure 1.1 The chemical equation of the Fenton reaction and Haber-Weiss reaction. 
Iron catalyses the Fenton reaction that generates reactive oxygen species (ROS), 
which are amplified within the Haber-Weiss reaction. 
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Figure 1.2 Proposed mechanisms in which iron is involved in the neurodegenerative 
process. Sources of iron include the a) transport across the blood brain barrier (BBB); 
b) release from ferritin stores. Labile iron catalyse the Fenton reaction and produces 
reactive hydroxyl radicals (OH*), which induce oxidative stress as a consequence of 
depletion of cellular antioxidants, and consequently leads to membrane lipid 
peroxidation, DNA damage and protein oxidation and misfolding. In addition, labile 
iron can induce aggregation of a-synuclein and amyloid-p, which are pro-oxidative 
and toxic Adapted from (Zecca et al, 2004). 
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1.1.3 Role of iron in neurodegenerative diseases 
A huge body of literature has provided strong evidence towards the notion that iron 
accumulation in the brain is deleterious. Iron overloading is one of the of factors 
causing neuronal death in a number of neurodegenerative disorders, notably 
Alzheimer's, Parkinson's, and Huntington's diseases as well as Hallervorden-Spatz 
syndrome. Evidences of the converging findings were derived from histochemical 
studies in diseased brain (Dexter et al., 1992; LeVine, 1997; Loeffler et al., 1995), 
spectroscopic and tomographic investigations (Collingwood et al., 2008), as well as 
magnetic resonance imaging (MRJ) studies (Bartzokis and Tishler, 2000; House et al., 
2007; Martin et al., 2008; Michaeli et al., 2007). Interestingly, abnormal iron 
accumulation were frequently reported in the diseased brain, and distinctively 
concentrated in brain areas most susceptible to the disorder (Ke and Ming Qian, 2003; 
Moos and Morgan, 2004; Ponka, 2004; Ponting，2001; Zecca et al” 2004). 
Further supports to this notion. For instance, mutations in genes encoding iron 
regulatory proteins were revealed in inherited neurodegenerative conditions. And 
ubiquitous failure of those iron regulatory proteins e.g. ferroxidases, ceruloplasmin, 
ferritin, and frataxin were found to be the cause (Chinnery et al., 2007; Mantovan et 
al., 2006; Zecca et al., 2004). 
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Added to that, iron is implicated in aging and cell death. As observed in other parts 
of the body, the brain accumulates iron in normal aging. Moreover, oxidative stress is 
one of the key mediators of apoptosis (Chandra et al., 2000; Green and Reed, 1998; 
Olanow et al., 1996; Sayre et al., 1999), of which the release of mitochondrial (iron 
containing) cytochrome c into the cytosol and the activation of caspase-3 are the two 
critical steps in apoptotic neuronal cell death (Cohen, 1997; Green and Reed, 1998). 
Interestingly, tremendous increase in intracellular iron was found at the time of cell 
apoptosis, whereas translocation of iron from lysosomes into mitochondria appeared 
to be a key event that leads to cell death (Uchiyama et al., 2008). In this regard, the 
limited regenerative capabilities of the brain explain why iron afflicts the central 
nervous system particularly. Therefore, these lines of evidences point to a causative 
role of iron in neurodegenerative diseases. 
1.1.4 Role of iron in Alzheimer's disease 
Alzheimer's disease (AD) is well acknowledged to be characterized by the amyloid 
plaques deposition. The major constituent of the amyloid plaques is the amyloid-P 
peptide (Ap). The glutamatergic synapse, the primary site of long term potentiation 
(LTP, see Section 1.4 below), is where amyloid first deposits in AD (Bamham and 
Bush, 2008). More interestingly, soluble Ap oligomers extracted directly from the 
7 
cerebral cortex of AD subjects were shown to potently impair LTP in normal rodent 
hippocampus (Shankar et al., 2008). 
Early studies have indicated that iron was concentrated within the vicinity of amyloid 
plaques (Connor et al., 1995). Indeed, the N-terminal region of Ap consists the 
metal-coordination structure, while iron is able to bind Ap and enhances its toxicity 
(Bush et al., 1994; Huang et al.，1999; Schubert and Chevion, 1995). In particular, 
3+ . 
Fe ions are found to bind to hyperphosphorylated Tau, which is involved in the 
formation of the neurofibrillary tangles (Shin et al., 2003). Surprisingly, the complex 
of Fe3+ ions and Ap, by themselves, are able to generate ROS in vitro (Adlard and 
Bush，2006), which affixes an evidence that the two players may work synergistically 
to exacerbate oxidative stress. Recently, a study reported that the total concentration 
2 + 
of Fe -ion-containing iron oxide and biogenic magnetite are leveled up in the AD 
(Pankhurst et al., 2008)，which signifies another interesting pathological aspect of 
iron on AD. These combined findings together ftirther support a participation of iron 
in the AD etiology. 
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1.1.5 Deleterious effects of iron in memory function 
Up to now, there are relatively few studies on the relationship between iron and 
memory function. Nevertheless there is evidence that iron may affect memory 
ftmctions mediated by hippocampus, the brain's memory-consolidation center at 
which the initial storage of declarative memory occurs (Squire and Zola-Morgan, 
1991). The hippocampus is one of the brain areas most susceptible to oxidative stress 
and iron overload (Youdim，2008). Iron content in this brain region was proven to be 
significantly increased with age (Qian et al., 2007). Clinically, hippocampal neuronal 
damage is an important hallmark of AD, and therewith, it has been reported that AD 
patients who undergone the iron chelator, desferoxamine (DFO) treatment had a 
reduced rate of cognitive decline (Crapper McLachlan et al , 1991). Added to that, 
DFO was found capable of reversing age-related long-term recognition memory 
impairment by reducing the oxidative damage to proteins in cortex and hippocampus 
(de Lima et al., 2008). These different pieces of evidence implicated the deleterious 
role of iron in memory function in diseased conditions. However, the role that iron 
plays in memory function in the normal brain remains largely elusive. 
9 
1.2 Iron regulation in the brain 
1.2.1 Transport and storage of brain iron 
The transport of iron across the capillary endothelium, as known from available data, 
is mainly through the transferrin/transferrin receptor (Tf^TfR) pathway. As depicted 
in Figure 3, the processes probably includes 1) the binding of iron-laden transferrin 
(Tf-Fe) to the extracellular portion of TfR, which induces the 2) endocytosis of the 
iron—Tf—TfR complex, followed by 3) the formation of endosome, and afterwards 4) 
dissociation of iron from Tf in the endosome, owing to the acidic endosomal 
microenvironment, the Fe^^ ion are then reduced to Fe^^ ion and eventually, 5) the 
Fe2+ ions are translocated across the endosomal membrane by the divalent metal 
transporter 1 (DMTl). At the same time, a small proportion of iron is transported 
across the blood-brain barrier (BBB) in the form of intact Tf-Fe complex via 
receptor-mediated transcytosis (Bradbury, 1997; Fleming et al., 1997; Gunshin et al., 
1997; Moos and Morgan, 2002; Qian et al., 1997). 
Cellular uptake of iron follows a similar mechanism. Iron is released from transferrin 
within the endosome and transported into the cytosol by DMTl. This cytosolic labile 
iron pool, the dynamic pool of iron readily available for utilization and redox 
1 0 
reactions (Kakhlon and Cabantchik, 2002; Kruszewski, 2003) would then be 
consumed in cellular processes or reserved (stored in ferritin, refer to Figure 1.4). 
The storage of iron is mainly carried through the ferritin protein. This protein retains 
ferric ions in the form of Fe .^-PCU crystal inside the internal cavity of its 
co-assembled shell (Rohrer et al., 1990). Ferritin is the universal intracellular iron 
storage protein found in all body tissues. And, it accounts for 33-75% iron storage in 
the brain (Beutler, 2007). 
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Figure 1.3 Proposed iron transport across the blood brain barrier. 1) Iron-laden 
transferrin (Tf-Fe) binds to the extracellular portion of TfR, which induces the 2) 
endocytosis of the iron-Tf-TfR complex, followed by 3) the formation of endosome, 
4) iron in the endosome then dissociates from Tf and reduced from Fe^^ ion to Fe^^ 
ion owing to the acidic endosomal microenvironment, and eventually, 5) the Fe^^ ion 
were translocated across the endosomal membrane by the divalent metal transporter 
1 (DMTl). Adapted from (Ke and Qian, 2007). 
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Figure 1.4 Cell uptake and utilization of iron. Extracellular diferric transferrin 
proteins are bound by the dimeric transferrin receptor and internalized by 
receptor-mediated endocytosis. Iron is then transported into the cytosol through 
DMTl. In the cytosol of mammalian cells, the assembly and disassembly of a 
[4Fe-4S] cluster in iron regulatory protein-1 (IRPl) and the iron-dependent 
degradation of iron regulatory protein-2 (IRP2) provide the mechanisms for sensing 
intracellular iron levels. In the tissues of healthy animals, most IRPl contains a 
[4Fe-4S] cluster and fiinctions as a cytosolic aconitase. Its homologue, IRP2, is 
therefore responsible for regulating the levels of the transferrin receptor and the iron 
storage protein ferritin (which can store up to 4,000 Fe atoms per molecule), as well 
as probably one isoform of DMTl and the iron exporter ferroportin, by binding to 
iron-responsive elements in their mRNAs. IRPl might contribute to iron regulation 
in pathophysiological situations. Adapted from (Rouault and long, 2005) 
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1.2.2 Iron homeostasis in the brain 
Iron level in the cells influence the iron regulatory proteins (IRP) binding to the 
iron-responsive elements (IREs) on the mRNAs of iron regulatory molecules (Pinero 
et al., 2000). The major iron import proteins are DMTl and TfR, while the iron 
exports proteins include ferroportin, ferroxidases, hephaestin and ceruloplasmin. Iron 
homeostasis is, principally, maintained by the IRE/IRP regulatory system, which 
modulates the expression of iron regulatory molecules in response to the cellular iron 
and ROS status (Caltagirone et al., 2001; Pantopoulos and Hentze, 1995). Those 
proteins include DMTl, TfR, ferritin, and ferroportin (Cox and Adrian, 1993; 
Gunshin et al., 2001; Thomson et al., 1999)，see Figure 1.5. It is noteworthy that 
APP mRNA, too, encodes a functional IRE (Rogers et al., 2002)，and added to that, 
dys-regulated binding oflRPs to IREs was reported in AD brain (Pinero et al., 2000). 
The major molecules participated in iron trafficking in various cell types in the brain 
are shown on Figure 1.6. In the brain, differential expressional pattern of iron 
regulatory protein exists across cell type. For instance, under the circumstances of 
iron deficiency, neurons increase TfR expression, which contrasts with astrocytes, 
oligodendrocytes, and microglia (Moos et al., 1998). This arrangement directs iron 
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supply to neurons ahead of other cell types in iron-depleted conditions, which 
underscores the distinctive importance of iron in neurons. 
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Figure 1.5 Cell regulation of iron by proteins that are principally controlled by the 
IRP system. Iron is taken up as the ferric form (Fe^^) by the TfR, enclosed in the 
endosome and converted into the ferrous form and afterwards released by DMT-1 
into the cytosol. The intracellular iron will a) be consumed and corporated into 
biomolecules, b) activate the IRP/IRE system, c) stored in ferritin or d) exported in 
the form of ferric iron. Adapted from (Lee et al, 2006). 
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Figure 1.6 Iron trafficking across cell types in the brain. There are two transport 
forms of iron in the brain: Tf-Fe and non-transfemn-bound iron (NTBI). Brain Tf is 
synthesized in either oligodendrocytes or epithelial cells of the choroid plexus. Tf-Fe 
is transport to neurons and astrocytes via a Tf/TfR pathway (blue arrows). NTBI, 
including lactoferrin bound iron (Lf-Fe^^) and secreted p97 bound iron (S-p97-Fe^"^), 
is delivered to neurons and astrocytes probably via DMTl- and trivalent 
cation-specific transporter (TCT)-mediated (purple arrows) pathway or lactoferrin 
receptor (LfR) and GPI-anchored p97-mediated pathway (black arrows), respectively. 
Adapted from (Ke and Qian, 2007). 
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1.2.3 Transport of iron in axon and synapse 
Anterograde axonal transport of iron was revealed when radiolabeled iron was found 
retaining in the brain regions where the projectional fields of neurons are located 
(Dwork et al.，1990). Furthermore, the ferritin peptide that was synthesized at the 
neuronal cell body, were reported harboring in the axons at their matured and 
assembled form (Curtis et al., 2001). Added to that, it has been shown that some of 
the ferritin is lysosomally degraded at distal axons and presynaptic terminals, which 
potentially release ferrous iron that could induce oxidative damage (Gunshin et al., 
2001; Schroder, 2005). Interestingly, ferroportin was found to be present in synaptic 
vesicles, which implicate a possible release of ferrous iron into the synapses (Rouault 
and Cooperman, 2006; Wu et al” 2004). The axonal trafficking of iron (as depicted 
on Figure 1.7)，suggests its functional importance in the axon and synapse, but also 
implicates the pathological significance of this localization at neurodegenerative 
conditions. The synaptic area can be the primary site of damage by iron 
dys-regulation, and in this regard, an adverse effect of overloaded iron, if any, on 
synaptic function may serve as a cause for the disease. 
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Figure 1.7 A schematic diagram illustrating the trafficking of iron in the neuron. The 
ferritin peptides are produced in the neuronal cell body, while the matured assembled 
heteropolymers are located within the axons. Lysomal degradation of ferritin in the 
distal axons and presynaptic terminals potentially results the release of ferrous iron in 
those region. Presence of ferroportin in synaptic vesicles signifies a possible release 
of ferrous ion into the synapse. Modified from (Rouault, 2001). 
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1.3 The hippocampus 
1.3.1 Hippocampus and memory function 
Human memory systems in the brain can be dissected into two major forms: the 
procedural (implicit) memory and the declarative (explicit) memory (Tulving, 1983). 
Procedural memory refers to memory for perceptual and motor skills. Systems 
responsible for memory of this kind include the cerebellum, the striatum, the 
amygdala, and as well, the simple reflex pathways at times of elementary instances. 
Declarative memory, on the other hand, refers to the recognition or recall of facts and 
events, which involve the medial temporal lobe and the hippocampus (Schacter and 
Tulving, 1994; Scoville and Milner, 1957; Squire, 1992). Declarative memory can be 
further divided into episodic memory (that functions for autobiographical 
information) and semantic memory (that serves the non-autobiographical facts and 
propositions). 
The hippocampus is well recognized as a key structure for learning and memory 
(Schacter and Tulving, 1994; Scoville and Milner, 1957; Squire, 1992). The 
discovery of the hippocampus memory function began with the study of the epilepsy 
patient H.M., who underwent bilateral medial temporal lobe resection that involved 
the removal of two thirds of his hippocampi. After the surgery, he performed well on 
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the procedural memory and other intellectual testing, yet suffered from severe 
anterograde amnesia. This surgical case, together with other later pieces evidence, 
revealed the importance of hippocampus for long term declarative memory function 
(Scoville and Milner, 1957). 
1.3.2 Structure of the hippocampus 
Hippocampus is one of the major components of the limbic system, meaning the "sea 
horse" in Latin. It exists as a curved tube in C-shape at the medial temporal lobe. 
This structure has been described as the shape of the sea horse, the silkworm and the 
banana (Duvemoy, 2005). The components of the hippocampus include the Comu 
Ammonis (CA) and dentate gyrus (DG), which form two interlocking U-shaped 
laminae. The detail structure of the hippocampus is illustrated on Figure 1.8. Its 
orientation and anatomical detail are depicted in Figure 1.9 (in the human brain), and 
Figure 1.10 (in the rat brain). 
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Cornu Ammonis (CA) 
Coronal division - The CA has a heterogenous structure along the coronal plane, 
which are grouped into four fields named CA1-CA4, as shown in Figure 1.8. CAl is 
the region that continues form the subiculum. It contains triangular, small and 
scattered pyramidal neurons. While in CA2, the somata of those neurons are ovoid, 
large and densely packed. CAS refers to the curved region of CA that protrudes to the 
concavity of the DG. This is where the fine, non-myelinated mossy fibers are located. 
CA4 is situated right within the concavity of the DG. Mossy fibers that originated 
from the DG at this location are large, intertwined and myelinated. The four CA 
regions are collectively termed as the "hippocampus proper", while the hippocampus 
proper added together with the dentate gyrus and subiculum are referred as 
"hippocampal formation". 
Laminar organization - The CA can be divided into six layers, counting from the 
ventricular cavity to the vestigial hippocampal sulcus: the alveus, stratum oriens, 
stratum pyramidale, stratum radiatum, stratum lacunosum, and stratum moleculare 
(Duvemoy, 2005). 
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Dentate Gyrus (DG) 
The DG consists of three neuronal layers: molecular, granular, and polymorphic. The 
granular layer is the most prominent which contains granule cells that project to the 
CA3 region. These granule cells are mostly connected to the intemeurons, and are 




Figure 1.8 General structure of the hippocampus depicted by the original Ramon y 
Cajal drawing (Cajal, 1911). 
2 3 
Lateral view Me<Bal v«Bw 
Hippocampus 丨‘ Hppocajrpus 
� W 
• Lateral venlndo Hippocampus 
謹 
Hippocamoua / j j \ 
nWnai Hh'ioal Ponrhmal Parahtppocarrspa/ 
(b) suicue cortw 
Figure 1.9 Hippocampus in the human brain (a) Location of hippocampus viewing 
from the lateral and medial plane, (b) The hippocampus and its nearby structures at 
coronal view. Adapted from (Bear et al, 2007). 
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Figure 1.10 Detailed structure of the hippocampal formation and the 
parahippocampal region in the rat brain. A. Lateral (left panel) and caudal (right 
panel) views. The hippocampal formation consist the dentate gyrus (DG; dark 
brown), CAS (medium brown), CA2 (not indicated), CAl (orange) and the 
subiculum (Sub; yellow). B. Nissl-stained horizontal sections (a, b) and coronal 
sections (c, d). Key regions were displayed as: the parahippocampal (green, blue, 
pink and purple shaded areas) and the entorhinal cortex: lateral (LEA; dark green) 
and medial (MEA; light green). C. Detailed structure on the diagram enlarged from 
(b). Adapted from (van Strien et al, 2009). 
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1.3.3 Cell composition in the hippocampus 
The majority of the neurons found in the hippocampus are the densely packed 
pyramidal neurons, while other cell types include the scattered basket cells at the CA 
and the tiny granule cells found in the DG (Olbrich and Braak, 1985). The pyramidal 
cells release glutamate as their neurotransmitter and function as the main excitatory 
component of the hippocampus. The granule cells in the DG, too, are glutamatergic 
neurons. The basket cells, on the other hand, are GABAergic and therefore function 
as inhibitory intemeurons. A pyramidal neuron typically carries a triangular soma, 
with its base facing the alveus，whereas its axons direct towards the alveus and 
project to the septal nuclei (Tamamaki et al., 1988). The principal connections of the 
hippocampal pyramidal neurons were shown on Figure 1.11. Some of the pyramidal 
axons are association fibers for one another and possibly connect towards the 
contralateral hippocampus. Schaffer collaterals exist on those axons that curve back 
into the stratum radiatum to reach other pyramidal neurons (Schaffer, 1892). The 
hippocampal pyramidal cells are sometimes called "double pyramidal" owing to its 
double dendritic trees structure, having its apical dendrite that extent far to the 
stratum moleculare, as well as its basal dendrites that connect to the stratum oriens. 
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Figure 1.11 Schematic overview of the principal connections of the hippocampal 
pyramidal neuron. 1-axon of a pyramidal neurons, 2-Schaffer collateral, 3-basket 
cells; 4-basal dendrites; 5-apical dendrites; 6-apical dendrites of a granular neuron. 
Modified from (Duvernoy, 2005) 
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1.3.4 Wiring in the hippocampus 
In a simplified model, hippocampus receives its major external input through the 
perforant path, at which axons from the entorhinal cortex (EC) synapse with the 
granule cells in the DG Signals from the DG then fire to the CA3 pyramidal cells via 
the mossy cell fibers. Through the Schaffer collaterals, input from the CAS are then 
transmitted to the CAl pyramidal cells. Information from the hippocampus finally 
exports from the CAl region to the subiculum. Collectively, the EC to DG (perforant 
path), DG to CAS (mossy fibres), and CA3 to CAl (schaffer collaterals) are called 
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Figure 1.12 The three major projection pathways within the hippocampus. Input of 
the hippocampus originates from the Entorhinal Cortex (EC), that connects the 
Dentate Gyms (DG) and CAS pyramidal neurons via the Perforant Path (PP), which 
is further divided into lateral (LPP) and medial (MPP). The DG projects its extension 
to CA3 neurons through the mossy fibres (MF). The CA3 neurons direct its axons to 
1) the CAl pyramidal neurons through the Schaffer Collateral (SC) pathway and 2) 
the CAl cells in the contralateral hippocampus via Associational Commissural 
pathway (AC). CAl neurons also receive input directly from the PP and transmit 
output to the Subiculum (Sb). A loop was formed when these neurons send the main 
hippocampal output back to the EC. Adapted from (Neves et al, 2008; Wang and 
Storm, 2005) 
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1.4 Synaptic plasticity and long term potentiation 
1.4.1 Basic theory of synaptic plasticity 
Synaptic plasticity is defined as the ability to change in synaptic connection and 
efficacy in response to the different nature of stimuli (Bear and Malenka, 1994). In 
1949，Donald O. Hebb hypothesized that sustained and coordinated activity within a 
group of neurons strengthens their synaptic connections, and subsequent stimulation 
of any member neuron can trigger the activation of the whole assembly, thereby 
recapitulating the original event encoded in that circuit. This postulation, known as 
the "Hebb's rule" or "Hebbian theory", has become the cornerstone in our 
understanding of the cellular basis of learning and memory. 
1.4.2 Types of synaptic plasticity 
Currently, various forms of synaptic plasticity were identified, including long-term 
potentiation (Bliss and Lomo, 1973), long-term depression (Dudek, and Bear, 1992), 
excitatory post-synaptic potential (EPSP)-spike potentiation (Abraham et al., 1985; 
Andersen et al , 1980)，spike-timing-dependent plasticity (Dan and Poo, 2004), 
depotentiation and de-depression (Barrionuevo et al., 1980; Dudek and Bear, 1993; 
Montgomery and Madison, 2002; Staubli and Lynch, 1990). Among them, the most 
well established and prototypic form of synaptic plasticity is the NMDA 
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receptor-dependent LTP in the hippocampal CAl region. 
1.4.3 The discovery of long term potentiation 
In the late 1960s, Terje Lomo and Timothy Bliss described the following 
phenomenon: with the use of a few seconds of high frequency electrical stimulation, 
a long lasting enhancement in synaptic transmission can be induced in the rabbit 
hippocampus (Bliss and Gardner-Medwin, 1973). This phenomenon, which follows 
the Hebb's rule precisely, was later referred to as long term potentiation (LTP). LTP, 
being defined as the long-lasting enhancement of synaptic efficacy that results from 
high frequency stimulation, has then been extensively studied through the 
electrophysiological, biochemical and molecular experiments. 
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1.4.4 Long term potentiation 
The critical role of LTP in memory has been evident from a huge body of literature. 
The blockage or removal of the molecular components crucial for hippocampal LTP 
results learning and memory impairment (Morris et al., 1986; Pastalkova et al., 2006; 
Rumpel et al., 2005; Shimizu et al., 2000). 
For the purpose of study, LTP is commonly dissected into three phases that occur 
sequentially, they are known as short-term potentiation, early phase LTP (E-LTP), 
and late phase LTP (L-LTP). Short-term potentiation, lasting from seconds to tens of 
minutes, is independent of protein kinase activity. E-LTP, which persists for 1 to 2 
hours, involves covalent modification of existing proteins and receptor trafficking at 
synapses, but not new protein synthesis (Lisman et al., 2002; Malenka and Bear, 
2004; Malinow and Malenka, 2002). L-LTP that lasts more then 3 hours is 
characterized by alteration in gene expression as well as de novo mRNA and protein 
synthesis (Atkins et al., 1998; Davis et al , 2000; Kelleher et al.，2004; Malleret et al., 
2001; Raymond et al., 2000). 
3 2 
1.4.5 Cellular mechanism of long term potentiation 
Induction of LTP requires coincident presynaptic and postsynaptic activity. The 
former signal mainly involves the glutamate release, whilst the later in general 
corresponds to depolarization. Glutamate released from the pre-synaptic terminal 
diffuses across the synaptic cleft and binds to both a-
amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) and 
N-methyl-D-aspartate (NMDA) receptors (Collingridge et al., 1983). The inflow of 
Na+ ions via AMPA receptors depolarizes the post-synaptic membrane to produce an 
excitatory post-synaptic potential (EPSP). When the post-synaptic cell is sufficiently 
depolarized, the Mg2+ ions blockade of the NMDA receptor is removed(Nowak et al., 
1984), allowing influx of Na+ and Ca^ "^  ions. In combination with the influx of Ca^^ 
ions via voltage gated calcium channels and mobilization of Ca^^ ions from 
intracellular stores, a critical surge of Ca^^ ions resulted. The Ca^ "^  ions interact with 
calmodulin, which then activates Ca^Vcalmodulin-dependent kinase II (CaMKII), 
and consequently phosphorylates existing channels and triggers receptors insertion to 
the synaptic membrane (Takahashi et al., 2003). CaMKII activity could also induce 
the production of retrograde messenger e.g. nitric oxide (NO) that diffuse to the 
pre-synaptic terminal and culminate the amount of neurotransmitter vesicle (see 
Figure 1.13). In addition, activation of other kinases in the cytosol by Ca^^ ions 
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contributes to the phosphorylation-dependent modification of the cytoskeleton and 
alternation of dendritic and axonal branching. The resulted structural changes in the 
shape and synapse number serves to facilitate the efficacy of potentiated pathways 
(Engert and Bonhoeffer, 1999). 
Mechanisms for L-LTP include the Ca^Vcalmodulin activation of adenylyl cyclases, 
which convert adenosine triphosphate (ATP) into cAMP, and thereby activate 
cAMP-dependent protein kinase (PKA). The PKA subsequently activates the 
mitogen-activated protein kinases (MAPKs), which contribute to the phosphorylation 
and activation of cAMP-responsive element binding protein (CREB). CREB, a 
transcription factor that governs the expression of a range of LTP related effector 
proteins (Dash et al” 1990; Yin et al., 1994)，triggers the transcriptional changes and 
protein expressions that subserve persistent enhancement of synaptic transmission 
(Abel et al., 1997; Alberini et al., 1995; Cooke and Bliss, 2006; Goelet et al., 1986; 
Nguyen and Kandel, 1997)，as illustrated schematically on Figure 1.14. 
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Figure.1.13 Summary of molecular mechanism underlying induction of E-LTP. 
Adapted fiom (Purves, 2008) 
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Figure.1.14 Summary of molecular mechanisms underlying E-LTP and L-LTP. 
Adapted from (Purves, 2008) 
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1.4.6 Role of reactive oxygen species in long term potentiation 
As noted in the preceding paragraphs, although excessive ROS is harmftil to cells, 
ROS act as cellular messengers in LTP. Tetanic stimulation was found to induce the 
generation of ROS that are required for synaptic plasticity (Hidalgo et al., 2007; 
Serrano and Klann, 2004). The rapid diffusion rate of ROS in lipid and aqueous 
environments accords their speedy signaling function. ROS can modulate the activity 
of a plethora of protein kinases and phosphatases, including the activation of protein 
kinase C (PKC), MAPKs, and the inactivation of calcineurin (Klann and Thiels，1999; 
Lander, 1997; Suzuki et al., 1997). 
The ROS that have been proven the LTP modulatory effects includes nitric oxide 
(NO), superoxide and hydrogen peroxide (H2O2). NO has been regarded as a 
retrograde messenger that is synthesized postsynaptically and work in both pre- and 
post- synaptic terminals (Ko and Kelly, 1999; Lu et al., 1999). It is well proven that, 
LTP facilitation is completely impaired by NO synthase inhibitors, which can be 
reversed by supplementation of exogenous NO (Bon and Garthwaite, 2003). 
Moreover, it has been reported that NO activates a presynaptic component of early 
LTP, such as the cascade composed of guanylyl cyclase (GC), cyclic guanosine 
monophosphate (cGMP)-dependent protein kinase, and ADP-ribosylcyclase. The 
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activation of GC-coupled NO receptors lead to the formation of cGMP, and 
subsequently trigger the downstream cGMP-dependent protein kinase pathway that 
modulate synaptic strength (Feil et al., 2005; Hawkins et al., 1998). Stimulation of 
ADP-ribosylcyclase, on the other hand, enhances the synthesis of cyclic adenosine 
diphosphate ribose (cADPR), a second messenger known to activate ryanodine 
receptors (RyR)-mediated calcium release (Galione and Churchill, 2002; Guse, 2005). 
For superoxide, its scavengers were shown to attenuate LTP at hippocampal CAl 
region (Klann, 1998). Interestingly, the level of superoxide was found to be elevated 
after NMDA receptor activation (Bindokas et al., 1996), which appears to mediate 
calcium-induced calcium release from intracellular stores via the RyRs (Huddleston 
et al., 2008). Besides, brief incubations of H2O2 with hippocampal slices were shown 
to enhance synaptic transmission (Katsuki et al., 1997). That finding is supported by 
the administration of catalase, the enzyme that decomposes H2O2, which abate LTP 
(Thiels et al., 2000，Knapp and Klaim, 2002). Since iron is a potent pro-oxidative 
catalyst, the ROS involvement in LTP has implicated an indirect effect of iron on the 
related mechanisms. 
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1.5 Aim of the study 
A bounteous pool of experimental and clinical reports has supported the association 
between iron level and neurodegenerative diseases (ND). Despite iron's notorious 
pro-oxidative properties and its deleterious relationship with ND's hallmark 
molecules, the exact role of iron in ND is largely unknown. An even more 
fundamental question is the role that iron plays in synaptic transmission and 
plasticity and the effect of excessive iron in these processes. At present, the answers 
to these questions are virtually unknown. We hypothesize that iron does play a role in 
synaptic transmission and plasticity and overloading of iron may impair these 
processes. To address these hypotheses, we aim to explore the effect of iron elevation, 
at both acute and chronic level, on basal glutamatergic synaptic transmission and 
long term synaptic plasticity. 
The specific objectives of this study are: 
(1) To investigate the effect of acute rise of extracellular iron in synaptic 
transmission and plasticity in the CA3-CA1 pathway in the hippocampus. 
(2) To study the effect of chronic and systematic iron elevation on long term 
synaptic plasticity in the same pathway. 
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2.MATERIALS AND METHODS 
2.1 Rat model of iron overload 
All experiments were performed in compliance with the National Institutes of Health 
guidelines for the handling of laboratory animals, which were approved by Animal 
Experimentation Ethical Committee of the Chinese University of Hong Kong. Efforts 
were made to minimize the number and suffering of animals. Animals were housed 
under room temperature on a 12-hour light and dark cycle, with free access to water 
and diet in standard rat cages of (18 x 35 x 55 cm). 
To generate iron-overloading in rats, subcutaneous injections of iron-dextran (Heibei 
Yuanzheng) were perfomed using two different doses (low dose: O.Olg Fe/dose and 
high dose: O.lg Fe/dose) at both short term (1 week) and longer term (4 weeks) 
treatment durations. Combinations of these paradigms generated 4 groups of iron 
treated animals, while 2 groups of animals receiving saline injections were served as 
the controls. The details on the 6 experimental groups were summarized in Table 2.1. 
Validation of the model was carried out by measuring the total iron content in various 
brain regions. The procedure is summarized in Section 2.4.2. 
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Experimental Low iron High iron Control 
Grouping 
Short term Injection of iron Injection of iron Injection of 0.9% 
(1 week) dextran(0.01 gFe/dose) dextran(0.1 gFe/dose) saline every other 
every other day. every other day. day. 
Total: 3 doses, 0.03g Total: 3 doses, 0.3g Total: 3 injections 
of iron. of iron. 
Long term Injection of iron Injection of iron Injection of 0.9% 
(4 weeks) dextran(0.01 gFe/dose) dextraii(0.1 gFe/dose) saline at 1-2 days 
at 1-2 days interval. at 2-3 days interval. interval. 
Total: 12 doses, 0.12g Total: 9 doses, 0.9g Total: 12 injections 
of iron. of iron. 
Table 2.1 Summary of the treatment paradigms in all the six experimental groups. 
2.2 Multi-electrode field potential measurement 
2.2.1 Acute preparation of hippocampal slices 
The animals were sacrificed by decapitation with a Stoelting decapitator after deep 
anesthetization by Isoflurane (Minrad, Inc). The entire brain was removed rapidly 
from the skull and soaked in ice-cold and carbogen (95%02, 5%C02) saturated 
artificial cerebrospinal fluid (ACSF)，which was made up of (in mM): 124 NaCl; 4.4 
KCl; 1.3 MgCl2.6H20; 1 NaH2P04； 26.2 NaHCOg； 10 D(+)-Glucose.H20; 2.5 
CaCl2.H20. Appropriate portions of the brain were trimmed, glued on the ice cold 
stage and sagittally sectioned at 280|im thick at the motorized vibrating microtome 
(Integraslice, Campden, UK). The described procedures were done within 20 min 
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after sacrifice in all cases. The slices were then hemi-transected to contain mainly the 
hippocampal formation and afterwards immersed in an incubation chamber with 
34°C of oxygenated ACSF. Electrophysiological recordings were followed after 2 
hours of slice recovery. 
2.2.2 Multi-electrode array recording system 
A planar multi-electrode recording setup, the 64-channel multi-electrode (MED64) 
system (Alpha MED sciences Co., Ltd., Tokyo, Japan)(Oka et al., 1999), was 
employed to record the field excitatory post synaptic potential (ffiPSP). In principle, 
this devise consists of four units: the integrated amplifier (SU-MED640), splitter 
(Med B02), connector, probe and the execution software (MED64 Recorder for 
Evoked Response), The hippocampal slices were gently positioned at the center of 
the 0.1% polyethyleneimine-coated multi-electrode dish (Bliss and 
Gardner-Medwin) probe which contains an array of 64 planar microelectrodes, each 
electrode size 20x20p-m and arranged in an 8 x 8 pattern with interelectrode spacing 
of 100|xm and 10mm of chamber depth (MED P210A; Alpha MED sciences Co., 
Ltd., Tokyo, Japan). A splitter is employed in this system, which separates the 64 
(8x8) array into 4 independent grids, so that simultaneous recording of 4 
hippocampal slices in maximum can be done at the same time. As a result, only the 
16 (4x4) microelectrodes at the center of the 64 microelectrodes of the Med probe 
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were applicable for fEPSPs recording at each hippocampal slice. The 16 (4x4) 
microelectrodes are able to cover the major hippocampal CAl region of the adult rat, 
and therefore is well fitted for the purpose of the experiments. 
2.2.3 Recording of field excitatory postsynaptic potentials 
The hippocampal slice was positioned on the probe with sufficient anchorage by a 
fine mesh net and an anchoring C-ring. The hippocampal slice was oriented on the 
Med probe in a position such that the CA 1 region weas properly accessed by the 
centre 16 (4x4) microelectrodes. This process was visualized through a digital 
microscope coupled with image capturing capability (MIC-D, Olympus Ltd., Japan). 
The probes were then placed on the connector of the MED64 system for field 
potential recording. Meanwhile, carbogen were infused through the opening hole on 
the cover of the probe to ensure ample oxygen supply to the hippocampal slice. The 
probe holding the slice was perfused with carbogen-saturated ACSF at a rate of 
2ml/min. Extracellular fEPSPs were synaptically evoked using biphasic constant 
current pulses (5-50 AA, 0.1 ms) through one of the 16 (4x4) microelectrodes. The 
stimulation electrode at the stratum radiatum was selected to stimulate the Schaffer 
collateral/commissural fibers projecting to the CAl region, which is the prototypical 
pathway for the study of LTP as well as spatial memory consolidation (Lynch, 2004; 
4 2 
Malenka and Bear, 2004). The elicited Schaffer collateral-CAl ffiPSPs were 
simultaneously hardware filtered through 0.1-10 kHz band pass and recorded by the 
MED64 system at a 20-kHz sampling rate. The stimulus intensity was determined as 
approximately 30-40% of the maximal signal amplitude, which were obtained from 
the input-output curve generated by the plotting of voltage response to gradual 
increment of stimulus intensity until the reaching of plateau. Data acquisition 
software (Alpha MED Scientific Inc., Japan) and isolator (Alpha MED Scientific Inc., 
Japan) were employed to convey stimulation patterns at 1-min intervals. Figure 2.1 
demonstrates the principal steps involved in the fEPSP recording on MED64 system. 
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hippocampal brain Slice C. Hippocampal slice overlying j ^ H 
planar electrodes on MED B ^ ^ ^ ^ B E ^ ^ ^ ^ S I ^ ^ ^ ^ B B ^ ^ ^ ^ B 
P�obe U m i I M ^ M H • _ • _ 
D. Acquired signals at 16 sites of the hippocampal 
Inter-electrode spacing: CA1 area 
100/zm 
MED probe 
Figure 2.1 Illustration of the ffiPSP recording on MED64 system. A) Preparation 
of hippocampal brain slice. B) MED probe consisting 64 microelectrodes at the 
center，which were arranged in an 8 x 8 pattern with interelectrode spacing of 100 
|im C) Image of a hippocampal slice placed on the Med probe. The purple square 
bounded the 16 (4x4) microelectrodes available for experimentation at each probe, 
the red square highlighted the stimulation electrode. D) Display of the acquired 
ffiPSP response from the 16 microelectrodes at the hippocampal CAl area. 
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In classical LTP recording, the slope of fEPSP was usually used as the measurement 
of the response of fEPSP. Nonetheless, as established in our laboratory, recordings of 
the fEPSP amplitude provide more stable thus more reliable data in our MED64 
array system. Therefore, we chose the amplitude of fEPSP rather than the slope of 
fEPSP as our main parameter of investigation in this study. 
As shown in Figure 2.2，a typical recorded fEPSP signal exhibits a) the stimulus 
artifact: the quick biphasic wave that was being recorded at the time of stimulus 
delivery, b) fiber volley: a tiny negative going curve immediately follows the 
stimulus artifact and c) the fEPSP: the most prominent curve following the fiber 
volley. The fEPSP, reflecting the direction of the synaptic current, is negative going 
when recorded at the dendritic layer of the CAl neurons. On the other hand, the fiber 
volley reflects the number of presynaptic axons being stimulated. In a healthy slice 
stimulation of a small set of presynaptic axons shall elicit a large synaptic response 
(large fEPSP amplitude). Therefore, the ratio of the fEPSP amplitude over the fiber 
volley amplitude reflects the physiological healthiness and thus was employed as a 







Stimulus artifact 2 0 m s 
Figure 2.2 The shape of a typical ffiPSP. The a) stimulus artifact, b) fiber volley and 
c) ffiPSP amplitude as indicated by the pink bracket, purple and cyan arrow 
respectively. 
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2.2.4 Induction of LTP 
After the establishment of a stable ffiPSP baseline (20-30mins), early phase LTP 
(E-LTP) was induced by a typical high frequency stimulation (HFS，1 train, lOOHz， 
pulse duration 0.2ms) that mimics the high intensity synaptic activity. The 
potentiated fEPSPs of the following 60 mins were then recorded. E-LTP was 
quantified as the percentage change in the average ffiPSP amplitude at the 50也-60^ 
min post E-LTP induction over the baseline average, see Figure 2.3. 
-900 
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HFS - High Frequency Stimulation 
1 train, 100Hz, 1s 
Figure 2.3 The profile of the ffiPSP amplitudes in a complete recording of E-LTP. 
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2.2.5 Recording of paired-pulse ratio 
Paired-pulse ratio (PPR) is defined as the ratio of the second evoked (test) response 
amplitude over that of the first (conditioning) elicited by the paired-pulse paradigm. 
The phenomena of paired-pulse facilitation (PPF) and depression (PPD) are the 
short-term form of use-dependent synaptic plasticity (Atwood and Wojtowicz, 1986; 
Fisher et al., 1997; Katz and Miledi, 1968; Zengel and Magleby, 1982; Zengel et al., 
1980; Zucker, 1989; Zucker and Regehr, 2002). PPR depends on the probability of 
presynaptic vesicles release, and therefore a change in PPR indicates a presynaptic 
alternation during the more persistent and complex forms of synaptic plasticity. 
In this experiment, paired-pulse consisting a pair of stimulation (5-50 AA, 0.1 ms) at 
50 ms interval was delivered, the pairs of fEPSPs elicited by the paired-pulse was 
then recorded. The paired-pulse stimulation was delivered at 1-min intervals, after 
the establishment of 20mins stable baseline, experimental drug was administered into 
the perfusion ACSF, and the fEPSPs recording was then continued for another 
20mins. Paired-pulse ratio was obtained by dividing the second over the first fEPSP 
amplitude (see Figure 2.4). The change of pair pulse ratio before and after the 
application of drug was compared afterwards. 
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\ I 100 uV 
V / 5ms 
Figure 2.4 A typical fEPSPs elicited by the paired pulse stimulation. Calculation of 
PPR is achieved by dividing the second fEPSP amplitude (b) over that of the first (a), 
hence PPR=b/a. 
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2.3 Whole cell patch-clamp recordings 
To assess the excitability of neurons before and after application of extracellular iron, 
hippocampal brain slices were prepared essentially as described in section 2.2.1, 
except that a thickness of 250^m was made, and that the recovery time in the 
incubation chamber was 1 hr instead of 2 hrs. After recovery, hippocampal slices 
were placed on a small-volume (0,5 ml) recording chamber on an upright microscope 
(Zeiss Axioskop), which were visualized by the differential interference contrast 
(DIG) optics aided through the contrast-enhanced video microscopy (Hamamatsu). 
The slices were anchored under the C-rings and were superfused with 
carbogen-saturated ACSF at 2ml/min flow rate. 
All recordings were carried on hippocampal CAl neurons which fulfill the following 
criteria: a smooth surface, three-dimensional contour, pyramidal in shape, and a 
resting membrane potential of at least -50mV. Single cell whole-cell patch clamp 
recordings were performed using a patch-clamp amplifier (MultiClamp 700A; Axon 
Instruments, Molecular Devices Corporation), digititized at lOkHz, and acquired 
through the 16-bit data acquisition system Digidata 1322A (Axon Instruments, 
Molecular Devices Corporation) under the control of pCLAMP 8.0 (Axon 
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Instruments, Molecular Devices Corporation). 
Patch pipettes were pulled from borosilicate glass (1.5mm O.D.，0.86mm I.D., Sutter 
Instrument Co.) by a Flaming-Brown (P-97; Sutter Instrument). Pipette resistance 
was typically 6-8 MQ when filled with low chloride internal solutions of the 
following composition: ISOmM K- gluconate; lOmM KCl; 2 mM MgCl2-6H20; 
O.lmM CaCb，lOmM HEPES; 2mM ATP-Na2； 0.5mM GTP-Na; and ImM EGTA; 
pH was adjusted to 7.25 - 7.3 with IM KOH. The patch pipette was appropriately 
positioned on the CAl neuron. After the pipette tip was in contact with the cell 
membrane as indicated with an increase in resistance, suction was then applied until 
the formation of gigaseal (electrical resistance > 1 GQ). Afterwards, a strong suction 
was delivered to break through the patch membrane, the whole cell configuration 
was then obtained. 
After the formation of a whole cell configuration, conventional whole-cell current 
clamp recording was initiated. The holding current was adjusted until the membrane 
potential was held at -70 mV or -55 mV respectively. A current steps protocol with 
successive current pulses, stepping up from -160 pA to +160 pA at 20 pA increments， 
at 200ms duration each, was delivered. Recordings of the voltage responses elicited 
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by the current step protocol were done in triplicate, at 10 minutes interval throughout 
the 30mins application and 20 mins washing of FAC. 
The stimulation protocol and the typical voltage responses are shown in Figure 2.5. 
The action potential frequency is the number of firing at each current step divided by 
the current pulse duration (200ms). The individual voltage traces elicited by each of 
the current step pulses were depicted on Figure 2.6. 
The action potential waveforms were analyzed on the first action potential initiated 
from the threshold step current. The action potential peak amplitude (voltage 
difference between the resting potential and the peak of the action potential), area 
(area bound by a complete action potential deflection against the resting potential), 
half-width (the width of the action potential at half-peak amplitude), maximum rise 
slope (maximum rising speed from the resting potential to the peak level of action 
potential) and maximum decay slope (maximum speed of dropping from the actional 
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Figure 2.5 The typical stimulation protocol and voltage responses of CAl 
hipppocampal neurons. Depolarizing and hyperpolarization current steps were 
applied between -160 pA and +160 pA in 20 pA increments (A). The typical 
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Figure 2.6 Representative individual voltage traces elicited by the current step 
pulses. Responsive traces in response to each current steps triggered at the initial 
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Figure 2.7 Parameters adopted for the analyzing the action potential. Blue arrows 
denote the peak amplitude (a) and half-width (b). Area shaded in grey stroke denotes 
the action potential area. Cyan dashed arrows delineate the maximum rise slope (c) 
and maximum decay slope (d) analysis. 
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2.4 Biochemical assays 
2.4.1 Preparation of brain homogenate 
After the completion of chronic iron injection paradigms, rats were first anesthetized 
by Isoflurane (Minrad, Inc), and deeply anesthetization by intraperitoneal injection of 
8% chloral hydrate. They were then transcardially perfused with phosphate-buffered 
saline (PBS). Brains were rapidly removed and placed on an ice cold stage. 
Aftereards, four brain regions: hippocampus, striatum, frontal cortex and cerebellum 
were dissected out immediately. The dissected brain tissues were weighted and 
cryopreserved by liquid nitrogen. Samples were stored at -70°C until assayed. 
2.4.2 Total iron measurement 
Total iron contents in the four brain regions were determined using a graphite furnace 
atomic absorption spectrophotometer (GFAAS, Perkin Elmer, Analyst 100). Brain 
tissues were diluted 1:20 (w/v) with 0.02M HEPES buffer and sonicated (Ultrasonic 
homogenizer VC-5DT, Vitra Cells™, Sonics & Materials Inc., Danbury, CT，USA). 
A 30-|LI1 portion of the homogenate was added to an equal volume of ultra-pure nitric 
acid in a 600 |il polypropylene microfuge tube, sealed by parafilm, and digested for 
48 h at 50�C. The sample was then diluted 1:40 with 3.12 mmol/L nitric acid. 
Standard curves ranging from 0 to 40 ppb were prepared by serial dilution of iron 
standard (500ug iron/dL, Sigma) with blanks prepared from homogenization reagents 
57 
in 0.2% nitric acid. Absorbance readings were recorded at 248.3 nm, slit: 0.2 nm, 
pretreatment temperature: 1,400°C，and atomization temperature: 2，400�C by the 
graphite furnace atomic absorption spectrophotometer. 
2.4.3 Protein carbonyl measurement 
Protein oxidation is defined as the covalent modification of proteins induced by 
reactive oxygen species (ROS) or the secondary by-products of oxidative stress. The 
most common form of protein oxidation in biological samples carries the carbonyl 
derivatives of the side chain amine groups of amino acids e.g. proline, lysine, 
arginine, threonine and histidine. These derivatives are chemically stable which serve 
as an index for most types of oxidative stress. 
Protein carbonyl contents in the four brain regions were measured using 
2,4-dinitrophenylhydrazine (DNPH) in a spectrophotometric assay(Levine et al., 
1990). Brain tissues were diluted at 1:20 (w/v) and sonicated in ice-cold 
homogenization buffer containing protease inhibitor (Sigma-P2714) in 5mM 
phosphate buffer (pH 7.5) with 0.1% Triton X-100. They were then centrifiiged at 
1000 X g at 4°C for 10 min to sediment insoluble material. 200^1 aliquots of the 
supernatant were treated with 200|LI1 of lOmM DNPH dissolved in 2 M HCl, at the 
58 
meanwhile, 200 aliquots of the supernatant was treated with 200ILI1 of 2 M HCl 
alone as the reagent blank. Samples were incubated for 1 h at room temperature in 
the dark and gently shaken continuously. Samples were precipitated with equal 
volume of trichloroacetic acid (TCA, final concentration 10%) and centrifliged at 
6,000 X g at 4°C for 5 min. The supernatant was discarded and the pellet was 
resuspended in 500 i^l of 10% TCA, sat for 5mins on ice, and centrifuged at 10,000 
xg at 4°C for 5 min. The pellet was then washed 3 times with 500 [i\ of ethanol/ethyl 
acetate (1:1 v/v), lightly vortexed and centrifuged at 10,000 xg at 4°C for 10 min. The 
final pellet was dissolved in 500|al of 6 M guanidine in 10 mM phosphate buffer (pH 
2.3 by trifluoroacetic acid), and the insoluble material was removed by centrifugation 
at 16,000 xg for 5 min. Absorbance was recorded at 366 nm for both DNPH-treated 
and HCl-treated samples. The recorded absorbance of the DNPH-treated sample was 
corrected by subtracting that of the HCl-treated control. Protein carbonyl levels were 
calculated as nm of carbonyl per mg of protein using max = 22,000 M'^ cm"^ 
(molar extinction coefficient for aliphatic hydrazones). 
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2.4.4 Determination of reactive oxygen species 
Dichlorodihydrofluorescein (DCFH)，one of the most frequently used probes for the 
overall oxidative stress detection, is a nonfluorescent fluorescin derivatives that can 
be oxidized by various oxidants to produce a green fluorescent product 
2’，7，-dichlorofluorescein (DCF). Brain tissues were diluted at 1:20 (w/v) and 
sonicated in ice-cold 0.02M 4-(2-hydroxyethyl)-1 -piperazineethanesulfonic acid 
(HEPES) buffer. 5\il of the brain homogenates were pipetted into non-transparent flat 
bottom 96-well plates (Nunc Black 96F MaxiSorp®) and 0.1-IM of H2O2 
were included as standard. 145|il of 0.02M HEPES containing the probe 
2',7'-dichlorodihydrofluorescein-diacetate (DCFH-DA, 10|iM final concentration) 
was added to each well and the plate was wrapped in aluminium foil to avoid 
photo-oxidation. The change in fluorescence after 20mins and 30 mins were 
measured using fluorescence spectrophotometer (Wallace Victor, 1420 Multilabel 
Counter) with excitation at 485 nm and emission at 530 run. The rate of change in 
fluorescence intensity was calculated and the ROS level was obtained from the H2O2 
standard curve. Results were expressed as the percentage of control. 
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2.5 Drugs and data analysis 
Unless otherwise stated, all chemicals were purchased from Sigma Chemical Co (St. 
Louis, MO, U.S.A.). Data from multi-electrode field potential recording were 
analyzed by the data acquisition software (Alpha MED Scientific Inc., Japan). 
Whole-cell patch clamp data analysis was performed in Clampfit 9.0 (Axon 
Instrument). All data were processed by Microsoft Excel 2007 for Windows 
(Microsoft, Redmond, WA) and SPSS 16.0 for Windows (SPSS Inc., Chicago, IL) 
and plotted with Prism 5 for Windows (GraphPad Software Inc., San Diego, CA). 
Results were expressed as mean 士 SEM. Unpaired Student's t-test was used to 
compare results between two groups; One-way ANOVA followed by post-hoc 
Dunnett's test (2-sided) were used to compare results between three or more groups. 
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3. RESULTS 
To elucidate the possible impact of iron on neuronal function, especially with regard 
to memory, both the acute, in vitro effect and the chronic, in vivo effects of a raised 
iron level on synaptic transmission and plasticity were studied in the hippocampus 
CAl region. In the first set of experiments, elevated extracellular iron was achieved 
by addition of ferric ammonium citrate (FAC) into the fluid superfiising hippocampal 
slices. The effects on basal synaptic transmission and long-term synaptic plasticity in 
the form of long-tem potentiation (LTP) were studied. In the second set of 
experiments, a detailed analysis was performed on the acute effect of FAC on the 
electrophysiological properties and the excitability of the neurons by means of the 
whole-cell patch-clamp technique. In the last set of experiments, multiple injections 
of iron-dextran into the rat were carried out to produce an iron-overloading model. 
The chronic effects of the elevated brain iron levels on hippocampal long-tem 
synaptic plasticity was examined and correlated to the generation of reactive oxygen 
species. 
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3.1 The acute effects of extracellular iron on synaptic 
transmission and long-term synaptic plasticity in the 
hippocampus in vitro 
Ferric ion, Fe^ ,^ is the dominating form of iron in the extra-cellular environment 
(Bradbury, 1993). We therefore chose to study the effects of the raising 
extracellualar ferric ion concentration in the artificial cerebrospinal fluid (ACSF) 
bathing the hippocampal slices. The source of ferric ion used in this study is mainly 
ferric ammonium citrate, or FAC, which is a readily dissolvable drug commonly 
used in iron homeostasis studies. To confirm the involvement of ferric ion, the 
actions of FAC on basal synaptic transmission and LTP were compared with that of 
ammonium citrate (AC) and ferric chloride (FeCb). 
3.1.1 Effects of ferric ion on basal synaptic transmission 
3.1.1.1 Effect of FAC on basal fEPSPs 
To investigate the effect of extracellular ferric ion on the glutamatergic transmission 
from CA3 to CAl subfields of the hippocampus, three concentrations of FAC were 
used, specifically 0.3|iM, 40|iM and 500|iM, which represent low dose, moderate 
dose and high dose of ferric ion respectively. Hippocampal slices were prepared as 
6 3 
described in the Materials and Methods section, and placed in the MED 64 probes 
such that the multi-electrodes gained access to the CAl stratum radiatum region. 
After stabilization, the Schaffer collaterals of the CA3 neurons were stimulated by a 
constant current pulse delivered at 1 min inter-pulse interval and the elicited ffiPSPs 
were recorded in the stratum radiatum. The amplitudes of the fEPSPs were 
monitored until a 20 min period of stable baseline was reached. The slice was then 
treated with O.S i^M, 40uM or 500|iM of FAC via the ACSF perfusion system. The 
changes of fEPSPs amplitude, if any, were recorded for the next 20 mins. For 
quantification, the fEPSPs amplitude during the 1 t o 20^ mins were averaged and 
analysed. Figure 3.1.1 A-C plot the fEPSP amplitude before and after FAC treatment. 
As summarized in Figure 3.1.ID, no significant changes of basal synaptic 
transmission were observed when FAC was applied at a concentration of 0.3|aM (101 
士 1.4%，n = 11，P>0.05) or 40|LIM (96 士 2.6O/O, n = 11，P>0.05). However, a 
significant reduction in the fEPSP amplitude was found using an FAC concentration 
of 500|LIM (87 土 6.80/0，N = 11，P<0.05). These results revealed a dose-dependent 
effect of FAC in impairing the excitatory CA3-CAl transmission in the hippocampus, 
the impairment reaches a significant value when a relatively high dose was used. 
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To determine if the inhibitory effect of 500|iM FAC on the synaptic transmission is 
via a presynaptic mechanism (i.e. reduction in transmitter release), or a postsynaptic 
mechanism (i.e. reduced response to the transmitter), we monitored the paired-pulse 
ratio (PPR) of the ffiPSP in one set of experiment. Paired electrical stimuli separated 
by 50 ms were delivered, and the ratio of the amplitude of the second ffiPSP over the 
first ffiPSP was measured throughout the 20 mins of FAC incubation. A change in the 
PPR usually indicates a pre-synaptic effect while no change in the PPR is taken as a 
post-synaptic effect. As seen in Fig. 3.1.2，there was no significant difference in the 
paired-pulse ratio of the ffiPSP before (1.5 士 0.10，n = 4) and after (1.5 土 0.08，n = 4， 
P>0.05) FAC treatment. These results suggest that FAC inhibits synaptic 
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Figure 3.1.1 Effects of acute FAC treatment on basal excitatory synaptic 
transmission. In the hippocampal CA3-CA1 pathway, no significant change in fEPSP 
amplitude were observed after application of FAC at 0.3 |aM (A) and 40|aM (B) but a 
significant reduction of fEPSP amplitude was found at the 500nM FAC (C). (D) 
Summary of the fEPSP amplitude change in response to different concentrations of 
FAC. Significant reduction of fEPSP amplitude was found at the 500|aM FAC 
concentration (*P<0.05, n = 11), whereas no significant change was found at 0.3|iM 
and 40|iM of FAC (n = 11 for both experiments). By one-way ANOVA, post hoc 
Dunnett test (2-sided). 
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Figure 3.1.2 No significant change in paired-pulse ratio of the ffiPSP was found 
after the hippocampal slices were treated with 500|iM of FAC (n = 4，P�0.05). By 
Student paired t-test 
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3.1.1.2 Comparison with the effect of AC on basal fEPSPs 
Although it is likely that it is the ferric ion dissociated from FAC that is responsible 
for the inhibitory action of FAC on the synaptic transmission, one cannot rule out the 
contribution by ammonium citrate (AC), especially given the fact that ammonium 
ion has been demonstrated to affect synaptic transmission and plasticity (Izumi et al., 
2005; Munoz et al., 2000). To solve this issue, we studied the effect of 
concentration-matched AC on the basal synaptic transmission, i.e. 20|j,M and 250)aM 
of AC for 40|AM and 500|LIM of FAC respectively. As seen in Figure 3.1.3， 
application of AC in replacement of FAC did not significantly affect the fEPSPs. The 
value of fEPSPs at the end of 20 mins of incubation with 20|IM of AC was 103 土 
2.3% of baseline (n = 8; P>0.05) while that of 250|LIM of AC was 95 土 2.1O/O (n = 8; 
P>0.05). These results rule out the possibility that the effect of FAC on synaptic 
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Figure 3.1.3. No effect of acute AC treatment on basal synaptic transmission. No 
significant change in ffiPSP amplitude was observed at the AC concentration of 
20|iM (A). A slight but insignificant decrease in ffiPSP amplitude was found at 
250|iM AC (B); Summary of the ffiPSP amplitude change in response to different 
concentrations of AC (n = 8 for each experiments) (C). By one-way ANOVA, post hoc 
Dunnett t (2-sided). 
7 1 
3.1.2 Effects of ferric ion on long-term synaptic plasticity 
3.1.2.1 Effect of acute FAC treatment on LTP 
The major objective of this study is to investigate the relationship between excess 
iron and long-term synaptic plasticity. Therefore, we studied the effect of the three 
concentrations of FAC (0.3 j^ M, 40^M and 500|uM) on the magnitude of LTP at the 
CA3 Schaffer collateral to CAl pathway in the hippocampal slices. After at least 30 
mins of stable recording of fEPSPs, high frequency stimulation (HFS), which 
consisted of 1 train of 100 Hz stimuli for 1 s, was delivered through the stimulation 
electrode. Post-tetanic potentiation of fEPSP for the next 60 mins was then recorded. 
As described in the Materials and Methods section, the magnitude of LTP was 
evaluated by the degree of fEPSP potentiation at the 50^ to 60^ mins after HFS 
induction, with reference to the pre-tetanus baseline. In the absence of FAC, HFS 
induced an LTP with a value of 151 土 5.7o/o (n = 13). Whilst a dose-dependent 
decrease in the magnitude of LTP caused by FAC was observed. For 0.3 ^ iM of FAC 
treatment, the LTP decreased to 137 土 4.7% (n = 11，P>0.05). FAC-induced 
impairment in LTP became significant at the higher FAC concentrations of 40|aM 
and 500|iM, which amounted to 112 土 6.2o/o (n = 11, P<0.001 compared with 
control) and 96 土 4.9%，(n = 11，P < 0.001 compared with control) respectively. 
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Figure 3.1.4 Effects of different concentrations of FAC on LTP expression in the 
hippocampal CA3-CAl pathway. An insignificant drop of LTP was observed with 
0.3|iM of FAC treatment (n = 11) (A). On the other hand, a significant reduction of 
LTP was found in 40^iM of FAC (***P< 0.001, n = l l ) (B)，and also 500|uM of FAC 
(***P< 0.001，n= 11) (C). Summary of the LTP induced by HFS under the effects of 
three concentrations of FAC (D). By one-way ANOVA, post hoc Dunnett t (2-sided). 
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3.1.2.2 Comparison with the effect of AC on LTP 
Again，in order to confirm a role of F e � . rather than ammonium citrate on LTP, we 
tested the effect of AC on LTP and compared with that of FAC. Experiments on 
HFS-induced LTP was conducted in the same way as in the previous section, except 
that AC was used instead of FAC. As can be seen in Figure 3.1.5，application of 
20|^M of AC (equivalent to that of40|iM of FAC) did not significantly affect the LTP 
magnitude, which was in contrast with that produced by 40|uM FAC. The magnitude 
of LTP under 20|LIM AC was 135 土 5.9O/O (n = 8，P>0.05 compared with control). 
When 250nM of AC was used, a significant reduction of LTP was observed, which 
scored the value of 115 土 6.0o/o (n = 8，PO.OOl compared with control). These 
results are summarized in Figure 3.1.5 
Since AC, like FAC, can impair LTP at high concentration, we compared statistically 
the effects of FAC and AC (of equivalent concentrations) on LTP. As shown in Figure 
3.1.6，the effects of FAC were significantly stronger than that of AC. These results 
show that while ammonium citrate can by itself impair LTP, while ferric ion alone 
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Figure 3.1.5 Effects of different concentrations of AC on LTP at 20|iM (A) and 
500|liM of AC treatment (B). Summary of the LTP magnitude in the presence of 
20|iM AC (P>0.05, n = 8) and 250|iM of AC (***P<0.001, n = 8) (C). By one-way 
ANOVA, post hoc Dunnett t (2-sided), 
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Figure 3.1.6 Comparison on the effects of FAC versus AC on LTP. Significant 
difference between the effect of 40|LIM of FAC and 2 0 | I M of AC (*P<0.05) (A) as 
well as 500|LIM of FAC and 250nM of AC (*P<0.05) (B) were found. By Student's 
t-test. 
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3.1.3 Effects of ferric chloride 
To ftirther confirm the inhibitory effects of ferric ion on LTP, we examined the effect 
of another ferric ion compound, FeCls. A concentration of 40)aM was chosen because 
as described in Sections 3.1.1 and 3.1.2, FAC at this concentration did not affect the 
basal synaptic transmission but impaired the LTP. As shown in Figure 3.1.7，FeCls at 
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Figure 3.1.7 No effect of FeCls on basal synaptic transmission. No significant 
change on fEPSP amplitude was found at the concentration of 40|aM FeCls (P>0.05, 
n = 8). The normalized fEPSP amplitude and a summary of the effect are shown in 
(A) and (B) respectively. By Student t-test. 
However, at this concentration, FeCls reduced the LTP magnitude to a significant 
extent. As shown in Figure 3.1.8，The LTP magnitude in the presence of 40|aM was 
found to be 118 土 4.0o/o (n = 8，P<0.001), which was similar to that produced in the 
presence of of 40|aM FAC (112 土 6.2o/o). These results confirm the role played by 
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Figure 3.1.8 Effect of acute FeCls treatment on LTP. Significant impairment on 
LTP was induced by 40|LIM of FeCls as shown on the time profile of the fEPSP (A). 
Summary of the effect ofFeCls on LTP (B). (n = 8，***P<0.001). Student's t-test 
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3.1.4 Effects of ascorbic acid on the action of FAC 
Since the production of reactive oxygen species (ROS) has always been implicated in 
the damaging effects of iron on cells, we tested the involvement of ROS in the effect 
of FAC in impairing LTP with the use of the anti-oxidant, ascorbic acid (vitamin C, 
VC). This essential vitamin is an important anti-oxidant in the brain. Its protective 
action against the oxidative stress induced by iron has been demonstrated before but 
not without controversy (Chen et al., 2000; Qiu et al., 2007; Rauhala et al., 1998). To 
elucidate if ascorbic acid can rescue or aggravate the suppressive effect of FAC, 
experiments were conducted to investigate the impact of ascorbic acid pre-treatment 
on the action of FAC. After 20 mins recording of stable fEPSP amplitude, the 
hippocampal slices were treated with ascorbic acid at either 0.5mM for 10 mins or 
2mM for 20 mins. As shown in Figure 3.1.9，ascorbic acid did not have any effect on 
its own on fEPSP, and did not alter the profile of fEPSP in response to FAC perfusion 
also. Furthermore, these two paradigms of ascorbic acid treatment did not affect the 
action of FAC in impairing the LTP. As shown in Figure 3.1.10, there were no 
differences in the LTP profiles between the groups of hippocampal slices treated with 
40 i^M of FAC with or without ascorbic acid. In FAC alone, the LTP magnitude was 
112 土 6.2% (n = 11) while it was 109 土 3.0o/o (n = 5) in 0.5mM ascorbic acid 
pretreatment and 123 土 11�A (n = 9) in 2 mM ascorbic acid treatment. In both cases, 
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no significant difference was found when compared with the control. These results 
suggest that the impairment of FAC on hippocampal LTP is not due to increased 
oxidative stress. 
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Figure 3.1.9 No significant effect of ascorbic acid on basal synaptic transmission 
and on the action of FAC. Normalized ffiPSP amplitude in lOmins of O.SmM 
ascorbic acid pretreatment followed by 20 mins 40|iM FAC (n = 5) (A) and 20mins 
of 2mM ascorbic acid followed by 20mins 40|LIM FAC (n = 9) (B), summarized data 
shown in (C) and (D) respectively. By one-way ANOVA, post hoc Dunnett t (2-sided). 
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Figure 3.1.10 No effects of ascorbic acid on FAC-induced impairment in 
hippocampal LTP. Comparison of the fEPSP profile in response to FAC application 
and HFS in the absence and presence of 10 mins pre-treatment with 0.5mM ascorbic 
acid (n = 5) (A). Effect of 20mins treatment of 2mM ascorbic acid (n = 9) (B). 
Summarized results are shown in (C). By one-way ANOVA, post hoc Dunnett t 
(2-sided). 
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3.2 The acute effect of extracellular iron on the membrane 
properties and excitability of hippocampal CAl 
neurons in vitro 
In view of the effects observed in the previous set of experiments that iron affect 
synaptic transmission and long-term potentiation, it is necessary to determine the 
effect of iron on the excitability and other membrane properties of hippocampal CAl 
neurons. To this end we performed whole cell patch clamp recordings from these 
neurons and assess the effect of acute administration of FAC. A detailed analysis of 
various parameters was made, and presented in the following sections. 
3.2.1 Membrane input resistance 
Membrane input resistances under the basal (before treatments), application of FAC 
(at 40^iM or 500|iM) and washing out of FAC were determined at 10 mins intervals. 
In the control experiments, perfusion of standard ACSF was maintained throughout 
the SOmins period of whole-cell recording. In the treatment groups, 40|LIM and 
500|iM of FAC were applied for 30mins in the perfusion, follow by washing out with 
standard ACSF for the next 20mins. The membrane input resistance was derived 
from the voltage response to -20pA current injection under the membrane potential 
of -70mV and -55mV. The two membrane voltages were chosen to cater for 
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membrane-potential dependent properties. Results were normalized to the basal 
membrane input resistance before treatments. The membrane input resistance was 
shown on Figure 3.2.1. Treatment of 500|iM FAC induced an observable reduction of 
membrane input resistance, which cannot be reversed by the washing step. However, 
the identified effect is insignificant as revealed in this experiment, extra experimental 
data may be required to confirm this observation. 
OuM FAC (Control) 
" • “ 40uM FAC 
500uM FAC 
Wash out 
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Figure 3.2.1 The effect of acute FAC treatments on the membrane input resistance of 
hippocampal CAl neurons. The number of cells in the control, 40|iM and 500|LiM of 
FAC were 4, 6 and 5 respectively. By repeated measures ANOVA, one way ANOVA. 
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3.2.2 Voltage-Current relationship 
Voltage-Current (V-I) relationship was investigated at the initial membrane potential 
of -55mV. A current steps protocol with 200ms hyperpolarizing and depolarizing 
pulses stepping up from -160pA to 160pA at 20pA increment was applied, and 
voltage responses obtained were complied on the V-I plot as shown in Figure 3.2.2. 
Linearity of the V-I curves lies between -lOOmV to -60mV. A minor deflection is 
recognizable from the curve of washing off 500|aM FAC, where the slope resistance 
is diminished, as identifiable on Figure 3.2.2C. And yet, this change carried no 
statistical significance and changes of the other V-I curves were negligible. 
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Figure 3.2.2 Voltage-Current plot before, after and washing of FAC. At the 
membrane potential of -55mV，change in the voltage-current response during 
experimentation of the control (A) 40|iM FAC (B) and 500|iM FAC (C). Data 
represent the mean ± SEM of 4, 6 and 5 cells for control, 40|iM and 500|aM of FAC 
respectively. By repeated measures ANOVA, one wayANOVA. 
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3.2.3 Membrane excitability 
The effect of FAC treatments on the membrane excitability of hippocampal CAl 
neurons was investigated via whole cell current clamp recording, in which the 
response of the hippocampal CAl neurons to direct somatic current injections was 
examined. At the holding potentials of -55 mV, a series of voltage traces were elicited 
by a 200-millisecond step depolarization from -160pA to 160pA at 20pA increment. 
The threshold of action potential firing, action potential firing frequency, and the 
action potential characteristic were presented in this section. 
3.2.3.1 Threshold current 
The threshold current is the amplitude of injected current required to elicit the first 
action potential. It reflects the excitability of the CAl hippocampal neurons, i.e. the 
lower the threshold current, the more readily those cells were being excited. Results 
are normalized to the basal value, at which no drugs were given, and the percentage 
change versus the basal value was illustrated on Figure 3.2.3.1. When the membrane 
potential was initially held at -55mV, a drop of threshold current was elicited after 
30mins of 500|iM FAC treatments. Contrasting results was observed between the 
40|iM and 500|iM of FAC treatments, whereas the threshold current was decreased 
and increased after 20mins washing off of 40|LIM and 500|IM FAC respectively. 
9 0 
• OuM FAC (Control) 
CZl 40uM FAC 
250-1 
E l 500uM FAC 
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Figure 3.2.3.1 The change in threshold current after the FAC treatments and wash 
off procedure. The change in threshold current after 40jiM and 500|xM of FAC 
treatments as well as that of the washing off, measured at the initial membrane 
potential of -55mV. The data were obtained from 4，5 and 5 cells in the experiments 
for control, 40|aM and 500|iM of FAC respectively. By one-way ANOVA, post hoc 
Dunnett t (2-sided). 
91 
3.2.3.2 Action potential firing frequency 
To investigate further the effect of FAC on the neuronal membrane excitability, the 
action potential firing frequency in response to different current steps at initial 
membrane potential of -70mV were elucidated. For the control experiment (Figure 
3.2.3.2A), where recordings were done without any treatments throughout the 
50mins whole cell current clamping, a slight increase of action potential firing 
frequency was observed during the 30^ and 50^ mins of recording, compared with 
the 0山 mins basal level. For the experiments with 40|iM FAC treatment (Figure 
3.2.3.2B), gradual increases in the pyramindal neurons' firing frequency was detected 
when comparing the basal, 40|^M FAC treatment and washing out respectively. The 
experiments with 500^M FAC, on the other hand, did not reveal any changes 
between the basal and 500|LIM FAC treatment, but elicited a distinctive drop of firing 
frequency during the wash out. 
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Figure 3.2.3.2 The frequency-current relationships of hippocampal CAl neurons 
before, after and the wash out of FAC. The AP firing frequency elicited by increasing 
injected current (+20pA to +160pA) before, after and the wash out of O i^M control 
(A), 40^M (B) and 500|iM (C) of FAC were presented. Each data point represents 
the mean � SEM of 4, 6 and 5 cells for control, 40|iM and 500^M of FAC 
respectively. By repeated measures ANOVA, one wayANOVA. 
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3.2.4 Action potential characteristics 
In a neuron, action potentials are initiated and modulated by an orchestra of voltage 
gated ionic conductances at the neuronal membrane. A change in action potential 
characteristics would indicate an alternation in these ionic conductances. To detect 
any of those alternations, a detailed quantitative analysis of the first action potential 
waveform induced by the threshold current was performed. Data were obtained from 
the experiments using the step current protocol at the initial membrane potential of 
-55mV as described in the previous section. 
3.2.4.1 Action potential amplitude, area and width 
As depicted on Figure 3.2.4.1 A, the action potential (AP) amplitude was elevated 
after the addition of both 40|iM and 500|aM FAC, whereas a greater increase in AP 
amplitude by 500fiM FAC was observed, and yet, this effect cannot be reversed by 
the washing off of FAC. For the AP area Figure 3.2.4.1B, both the FAC treatments 
exerted no effect on the AP area. However, an apparent reduction was manifested 
during the washing off of both concentration of FAC. Concerning the AP half width 
(Figure 3.2.4. IC), it was diminished following the application of both concentration 
of FAC, and this reduction is even intensified by the wash off steps. Under the 
treatment of FAC, a general trend of elevated AP amplitude but reduced half-width 
(duration) was found which bring about the unaltered value of AP area. A dose 
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dependent effect of FAC treatment can be observed, where the effect of 500|iM FAC 
is slightly greater than that of 40)aM FAC. However, those changes are not 
statistically significant in the current set of experiments. 
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Figure 3.2.4.1 The change in action potential characteristics after the application 
and wash out of FAC. Action potential amplitude (A), action potential area (B), 
action potential half-width (C) obtained from initial membrane potential of -55mV. 
Each data point represents the mean% 士 SEMo/o of 4，6 and 5 cells for control, 40|iM 
and 500|iM of FAC respectively. By one-way ANOVA, post hoc Dunnett t (2-sided). 
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3.2.4.2 Rise and decay kinetics of action potential 
As interpreted from the results of action potential half-width, the duration of action 
potential appeared to be decreased after the treatment of FAC. To elucidate further 
on the nature of this reduction, the rise and decay kinetics of action potential were 
analyzed. As illustrated on Figure 3.2.4.2，the maximum rise slope and maximum 
decay slope appeared to be increased after the FAC treatments. Both the rise and 
decay kinetics contribute to the shortened action potential duration. Again, however, 
those changes are not statistically significant in the current set of experiments. 
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Figure 3.2.4.2 The change in rise and decay kinetics of action potential after the 
application and wash out of FAC. Maximum rise slope (A) and maximum decay 
slope (B) obtained from initial membrane potential of -55mV. Each data point 
represents the mean% 士 SElVP/O of 4, 6 and 5 cells for control, 40|LIM and SOO^ IM of 
FAC respectively. By one-way ANOVA, post hoc Dunnett t (2-sided). 
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3.3 The chronic effects of iron-loading in the brain on 
hippocampal long-term synaptic plasticity 
3.3.1 Validation of the iron-overload model 
As described in Materials and Methods section, different injection protocols were 
used to generate iron-overloading in the rats, namely low dose and high dose of 
iron-dextran for both short-term and long-term. To validate the effectiveness of the 
different paradigms in causing iron-overload in the rat brain, as well as to test the 
impact of dosage level and treatment time, we examined the total iron content 
accumulated in the brain, in particular the hippocampus, and three other 
representative brain regions including the frontal cortex, the striatum and the 
cerebellum. 
3.3.1.1 Short-term (1 week) treatment 
Subcutaneous injection of low dose (3 doses each of 0.0 Ig Fe) of iron dextran within 
one week induced only a minute raise of total iron in the hippocampus (298.1 土 19.4 
nmol/g wet wt., n = 7) as compared with the control (285.0 土 9.8 nmol/g wet wt., n 
=6, P>0.05). In contrast, a significant elevation of total iron in the hippocampus was 
resulted from the high dose (3 doses each of O.lg Fe) treatment (388.3 土 20.5 
nmol/g wet wt., n = 8, P<0.01), which represented an increase of about 30% in iron 
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compared with the control group. Analyses on the three other brain regions yielded 
similar patterns. The results are summarized in Table 3.3.1 and also Figure 3.3.1. 
Brain region Total iron level (Mean 土 SEM nmol/g wet weight) 
Control Low-dose iron High-dose iron 
Hippocampus 285.0士9.8，n = 6 298.1土 19.4, n = 7 **388.3士20.5’ n = 8 
Striatum 296.7士 13.9，n = 7 309.3士 13.7, n = 7 •••420.7±14.3, n = 9 
Frontal cortex 298.8士 11.89，n = 8 311.2±13.8, n = 7 **393.6士26.5, n = 8 
Cerebellum 323.6士9.0, n = 8 339.6士19.6，n = 7 •*431.9±26.0, n = 7 
Table 3.3.1 Summary of the total iron content in the hippocampus, striatum, frontal 
cortex and cerebellum after short term low dose and high dose of iron injection. By 
one-way ANOVA, post hoc Dunnett t (2-sided). **P<0.01，***P<0.001 
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Figure 3.3.1 Total iron contents in the hippocampus (A), striatum (B), frontal cortex 
(C) and cerebellum (D) after 1 week treatment of low dose and high dose 
iron-dextran injection paradigms. All of the four brain regions produce similar 
pattern of response to iron injection, that is, an insignificant rise in the low dose 
group but a significant increase in the high dose group. By one-way ANOVA, post hoc 
Dunnett t (2-sided). **P<0.01, ***P<0.001 
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3.3.1.2 Long-term (4 weeks) treatment 
For the longer term (4 weeks) treatment, subcutaneous injection of low dose (12 
doses each of 0.01 g Fe) of iron-dextran again did not significantly raise the total iron 
contents in the four regions sampled. The total iron content after the treatment in the 
hippocampus was 314.7 士 15.9 nmol/g wet wt. (n = 8) while that of the control group 
was 265.3 士 11.70 nmol/g wet wt. (n = 8，P>0.05). On the other hand, significant 
increases in total iron contents in all of the four regions were found after the high 
dose (9 doses each of 0.1 g Fe) treatment. In the hippocampus, the value was 430.0 士 
21.3 nmol/g wet wt. (n = 8，PO.OOl)，accounting for more than 60% increase in iron 
content. Analyses on the three other brain regions yielded similar patterns. The 
results are summarized in Table 3.3.2 and also Figure 3.3.2 
Brain region Total iron level (Mean 土 SEM nmol/g wet weight) 
Control Low-dose iron High-dose iron 
Hippocampus 265.3士 11.7, n = 8 314.7士 15.9, n = 8 ***430.0±2L3, n = 8 
Striatum 328.0士8.2，n = 7 355.3士 12.7，n = 9 ***466.3士 14.5，n = 7 
Frontal cortex 289.7士 19.8，n = 8 357.4士18.8，n= 10 ***451.9±22.8, n = 8 
Cerebellum 336.0±19.7, n = 8 377.2士 19.2, n = 8 ***512.4±25.4, n = 9 
Table 3.3.2 Summary of the total iron content in the hippocampus, striatum, frontal 
cortex and cerebellum after long term low and high dose iron treatments. By one-way 
ANOVA, post hoc Dunnett t (2-sided). ***P< 0.001 
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Figure 3.3.2 Total iron contents in the hippocampus (A), striatum (B), frontal cortex 
(C) and cerebellum (D) after long term low dose and high dose iron-dextran 
injections. All of the four brain regions produce similar degree of iron overloading, 
namely, a trend of iron elevation in the low dose group and a statistically significant 
rise in the high dose group. By one-way ANOVA, post hoc Dunnett t (2-sided). 
***P<0.001 
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3.3.2 Effects of chornic iron-overloading on LTP 
3.3.2.1 Short term iron treatment 
At the termination of one week iron-dextran injection treatment, the rats were 
sacrificed and hippocampal slices were dissected out for LTP measurement, 
following the same procedure as described in section 3.1 on the acute effect of iron. 
As shown in Figure 3.3.3，a reduction in the magnitude of the LTP was found in the 
high dose group. In the saline-injected control group, the LTP magnitude was 165 士 
4.6% (n = 18) and in the high dose group, it was 151 士 3.2o/o (n = 16, P<0.05). In 
contrast, and intriguingly, an enhancement of LTP was detected in the low dose 
group (191 士 6.3，n = 10，P < 0.01). The data are summarized in Figure 3.3.4. These 
results show that iron over-load has a biphasic effect on the expression of LTP. 
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Figure 3.3.3 Hippocampal LTP in rats following short term high dose iron 
injection treatments. LTP was induced by HFS (1 train, lOOHz，Is) after 30 minutes 
recording of stable baseline. The ffiPSP profile (A) and the magnitude of LTP (B) 
from rats with high dose iron treatment. By one-way ANOVA, post hoc Dunnett t 
(2-sided). *P< 0.05 





Q. "i-T _ 
I g 2 � � - l ^ W t o M i ^ ^ ^ 2�邮 
•O 150- • Low Fe 
N 3 mmm •wmm 
1 1 1 � � - " - " ~ ~ —yf^ 
Z 1 / O.SmV 
50- ^ 
20ms 
1 1 1 1 1 




圣 Control Low Fe 
Figure 3.3.4 Hippocampal LTP in rats following short term low dose iron injection 
treatments. LTP was induced by HFS (1 train, lOOHz, Is) after 30 minutes recording 
of stable baseline. The ffiPSP profile (A) and the results of LTP (B) from rats with 
low dose iron treatment. By one-way ANOVA, post hoc Dunnett t (2-sided). **P< 
0.01 
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3.3.2.2 Long term iron treatment 
The effects of long term treatment of iron injection were essentially similar to that of 
the short-term treatment. As can be seen in Figure 3.3.5, high dose iron decreased the 
magnitude of fEPSP potentation towards the end of 60 minutes after the HFS. The 
LTP magnitude was 147 士 3.4o/o (n = 8), which was significantly lower than the value 
of 161 士 3.8% (n = 9，P<0.05) in the control. On the other hand, an enhancement of 
LTP was found in the low-dose group, with a magnitude of 179 ± 4.9 (n = 9, P<0.05 
compared with control). These data are summarized in Figure 3.3.6. 
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Figure 3.3.5 Hippocampal LTP of rats following long term high dose iron 
treatments. The ffiPSP profile (A) and the magnitude of of LTP (B) from rats with 
high dose iron treatment. By one-way ANOVA, post hoc Dunnett t (2-sided). *P<0.05 
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Figure 3.3.6 Hippocampal LTP of rats following long term low dose iron 
treatments. The fEPSP profile (A) and the results of LTP (B) from rats with low dose 
iron treatment. By one-way ANOVA, post hoc Dunnett t (2-sided). *P< 0.05. 
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3.3.3 Oxidative stress measurement 
Regardless of the duration of treatment, LTP was found to be enhanced and impaired 
in rats that received low and high dosages of iron treatments respectively. Since it has 
been reported that ROS has a biphasic effects on LTP (Knapp and Klaim, 2002) and 
that iron is a catalyst for ROS production, it would be interesting to examine the 
level of oxidative stress in our in vivo iron-overloading model, which may correlate 
with the effects on LTP. The degrees of oxidative stress were compared by two 
indices, namely protein oxidation and the level of ROS. 
3.3.3.1 Protein oxidation 
One of the suspected causes of the iron induced LTP impairment is the alternation of 
functional proteins critical for LTP establishment. ROS and its secondary 
by-products can cause damage to proteins via covalent modification, a process 
known as protein oxidation. Since the most common form of protein oxidation in 
biological samples manifest the carbonyl derivatives of amino acids, the protein 
carbonyl level in the hippocampus was investigated in the iron-overloading model. 
Three other brain regions, namely striatum, frontal cortex and cerebellum were also 
investigated. 
I l l 
In the short-term (1 week) treatment group, a significant elevation in hippocampal 
protein carbonyl content was found in the rats with high dose iron treatments. On the 
other hand, a slight but insignificant rise of protein carbonyl level was observed in 
rats with low dose iron treatment. Three other brain regions follow a similar pattern, 
except that the increase in carbonyl content in the cerebellum in the high dose group 
was more remarkable. The data are summarized in Table 3.3.3 and Figure 3.3.3.1. 
Brain region Protein carbonyl level (nmol/g) 
Control Low-dose iron High-dose iron 
Hippocampus 126.8±8.4, n=5 137.9士7.2，n=7 **174.4±9.4, n=8 
Striatum 149.6士9.7，n = 4 156.1 士8.6，n = 5 *195.5士 13.5，n = 5 
Frontal cortex 136士9.1, n = 6 150.8士7.5, n = 4 * 172.1 士9.1, n = 4 
Cerebellum 240.7士 14.4，n = 5 271.5士27.6，n = 6 •*412.9±42.5, n = 6 
Table 3.3.3 Summary of the protein carbonyl level in the hippocampus, striatum, 
frontal cortex and cerebellum after short term low and high dose of iron treatments. 
By one-way ANOVA, post hoc Dunnett t (2-sided). *P<0.05, **P<0.01 
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Figure 3.3.7 Elevations of protein carbonyl content in the hippocampus (A), striatum 
(B), frontal cortex (C) and cerebellum (D) after short term low and high dose iron 
treatments. By one-way ANOVA, post hoc Dunnett t (2-sided). *P<0.05，**P<0.01, 
***P<0.001. 
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The results from long term iron treatment closely resemble that of the short term 
treatment. Protein carbonyl level in the hippocampus was elevated significantly after 
long term high dose treatment, whilst a trend of increase could be observed in the 
low dose treatment group. Similar patterns were observed in the striatum and cortex, 
while the cerebellum has shown a more substantial exacerbation of protein oxidation. 
The numerical data and summary are presented in Table 3.3.4 and Figure 3.3.3.2 
Brain region Protein carbonyl level (nmol/g) 
Control Low-dose iron High-dose iron 
Hippocampus 145.8士 10.8，n = 6 157.6士 10.2，n = 4 **194.9±9.6, n = 6 
Striatum 161.8士6.0, n = 5 167.1 士7.3，n = 5 **202.7士9.1，n = 4 
Frontal cortex 130.3士4.1，n = 6 150.8士7.8，n = 7 *175.3士 10.3, n = 4 
Cerebellum 254.8士27.3, n = 6 *344.7士25.9，n = 7 ***546.3士47.0, n = 7 
Table 3.3.4 Summary of the protein carbonyl levels in the hippocampus, striatum, 
frontal cortex and cerebellum after long term low dose and high dose iron treatments. 
By one-way ANOVA, post hoc Dunnett t (2-sided). *P< 0.05, **P<0.01，***P<0.001. 
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Figure 3.3.8 Elevations of protein carbonyl content in the hippocampus (A), 
striatum (B), frontal cortex (C) and cerebellum (D) after short term low dose and 
high dose iron treatments. By one-way ANOVA, post hoc Dunnett t (2-sided). 
*P<0.05, **P<0.01, ***P<0.001. 
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3.3.3.2 Reactive oxidative species level 
Dichlorodihydrofluorescein (DCFH), a chemical that can be converted by various 
oxidative radicals to a green fluorescent product, is one of the most frequently used 
probes for detecting the overall oxidative stress in biological systems. In this study, 
DCFH assay on the brain homogenate of the hippocampus and the three other brain 
regions in the iron loaded models were performed. The value of ROS level is 
expressed as the percentage over control. 
In the hippocampus of rats with short term treatment, high dose of iron significantly 
increased the ROS content. On the other hand, no change was observed in the 
low-dose group. The pattern of ROS changes in the striatum, frontal cortex and 
cerebellum were very much the same. These data are summarized in Table 3.3.5 and 
Figure 3.3.9. 
Brain region Reactive oxygen species level (% of control 士 SEM%) 
Control Low-dose iron High-dose iron 
Hippocampus 100.0士2.4，n = 8 101.0士4.2，n = 5 **112.8土3.0，n = 10 
Striatum 100.0士 1.4，n = 9 95.6士2.7’ n = 5 **112.5±4.3, n = 10 
Frontal cortex 100.0士4.8，n = 6 100.5士2.7, n = 9 *112.2±2.9, n = 10 
Cerebellum 100.0±2.5, n = 10 97.6士4.2’ n = 8 **114.8士4.0，n = 11 
Table 3.3.5 Summary of the ROS level in the hippocampus, striatum, frontal cortex 
and cerebellum after short term low and high iron dose treatments. By one-way 
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Figure 3.3.9 ROS profile in the hippocampus (A), striatum (B), frontal cortex (C) 
and cerebellum (D) after short term low and high iron treatments. Significant 
increase of hippocampal ROS level was found in the high dose groups. Similar 
pattern was observed in the striatum, cortex and cerebellum. By one-way ANOVA, 
post hoc Dunnett t (2-sided) **P<0.01 
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Congruent with the other results in the in vivo models, long term high dose iron 
treatment induced a rise in ROS level，which was significant in all brain regions 
except the striatum. On the other hand, no changes in the ROS content was found in 
low dose group for all the brain regions sampled. These findings are summarized in 
Table 3.3.6 and Figure 3.3.10. 
Brain region Reactive oxygen species level (% of control 士 SEM%) 
Control Low-dose iron High dose iron 
Hippocampus 100.0士2.61，n = 15 105.2士2.94，n = 12 **113.2±3.22, n = 15 
Striatum 102.6士4.23，n = 14 104.5士3.79, n=12 112.6士3.48，n = 16 
Frontal cortex 100.0士3.10’ n = 16 99.27士3.05，n= 15 *113.4士3.26，n= 14 
Cerebellum 100.0士4.12，n = 16 98.04士3.22，n = 10 *113.7士2.71, n= 14 
Table 3.3.6 Summary of the ROS level in the hippocampus, striatum, frontal cortex 
and cerebellum after long term low dose and high dose iron treatments. By one-way 
ANOVA, post hoc Dunnett t (2-sided). *P<0.05, **P <0.01. 
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Figure 3.3.10 ROS profile in the hippocampus (A)，striatum (B), frontal cortex (C) 
and cerebellum (D) after long term low and high dose iron treatments. Significant 
increase of hippocampal ROS level was found in the high dose groups. Similar 
pattern was observed in the striatum, cortex and cerebellum. By one-way ANOVA, 
post hoc Dunnett t (2-sided). *P<0.05, **P<0.01 
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4. DISCUSSION 
A huge body of literature has reported that iron accumulation is associated with 
neurodegenerative diseases. A number of biochemical studies have also provided 
evidences that elevation of iron level can impose oxidative damage and exacerbate 
cell apoptotic processes. Therefore, there are good reasons to speculate that iron 
accumulation is a causative agent in these neurodegenerative disorders. While this 
issue is interesting and worth pursuing, the possibility of iron effectuated impairment 
on normal brain functions has not been well addressed. This is an important question 
because the deterioration of neurocognitive functions is a key symptom in the early 
stage of neurodegenerative diseases. Understanding the mechanisms not only aid the 
development of appropriate treatment paradigms but also provide clues to the 
designation of novel therapeutic targets. The major aim of the present study is to 
investigate how iron accumulation affects normal synaptic transmission, long-term 
synaptic plasticity and the membrane properties of neurons, using both acute in vitro 
as well as chronic in vivo models. We found that elevated level of extracellular iron 
does impair normal excitatory synaptic transmission and hippocampal long-term 
potentiation. However, iron does not affect the excitability and other membrane 
properties of the neurons significantly. These data are the first of its kind in the quest 
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for understanding the impact of iron accumulation in neuronal functions. 
4.1 Acute, in vitro effects 
The first set of in vitro experiments reveal that raising the extracellular ferric ion 
level in the form of FAC until 500|iM impairs the basal synaptic transmission of the 
glutamatergic CA3-CAl pathway. On the other hand, FAC reaching the 40|iM level 
is enough to impair LTP significantly. Our data shows that while the basal synaptic 
transmission is more tolerant to a rise in extracellular ferric ion concentration, LTP is 
much more sensitive to the elevation in iron level. 
The concentration of iron in normal cerebrospinal fluid (CSF), which closely 
resembles that of the brain interstitial fluid, had been reported in various studies. The 
reported iron content range from 22 ± 13 |ig /L (Nischwitz et al., 2008)，3.00 士 2.01 
^g/dL (Mizuno et al., 2005)，61.01 士 18.3 i^g/L (LeVine et al, 1998) to 73 士 73 i^g/L 
(Forte et al., 2004)，which corresponds to 0.4-1.3|iM. Besides, the level of 
nontransferrin-boimd iron can reach the level of ImM as observed in children 
suffered from acute iron poisoning (Cheney et al., 1995). Therefore the FAC 
concentration that we used in the present experiment, specifically 0.3|iM, 40|j,M, 
500jj,M covers the normal (low dose) and the diseased (high dose) range of 
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extracellular iron concentration. Our experiment reveals that LTP begins to slightly 
decrease by 0.3|iM of FAC and significantly impaired by 40\xM of FAC. This finding 
implies that slight elevation of extracellular ferric ion above the normal range may 
contribute inhibitive effect on the hippocampal learning and memory process. 
In order to verify that the effects of FAC are mediated by ferric ion per se, two sets 
of control experiments were performed. Application of ammonium citrate (AC), at 
the concentrations equivalent to that of FAC, reveals that AC alone can also impair 
LTP. This finding is in line with the previous reports on the inhibitory effect of 
ammonium ion on LTP (Izumi et al., 2005; Mimoz et al., 2000). However, the 
potency of FAC was shown higher than that of AC, suggesting that ferric ion does 
contribute to the observed phenomenon. Moreover, our experiment on 40|iM of 
FeCls (but not on 500|iM FeCla owing to the formation of colloidal complex at that 
concentration) has further confirmed the suppressive effect of ferric ions on LTP. 
With the inhibitive effect of acute ferric ion being proven, the immediate question 
raised is what are the mechanisms underlying the effect of this metal ion on both 
synaptic transmission and LTP? Our finding of the unaltered fEPSPs' paired-pulse 
ratios by FAC suggests that the site of ferric ion action is on the post-synaptic rather 
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than the presynaptic side. 
To obtain a more comprehensive picture of the acute effect of iron on neurons, and to 
elucidate its mechanism of action on synaptic transmission and plasticity, we 
compared in detail the neuronal excitability and action potential properties of CAl 
neurons in the presence and absence of FAC. As described in the Result section, no 
statistically significant differences were observed in this set of data, although there 
are observations pointing to the reduction of membrane excitability by a high 
concentration of FAC. This response reflects a subtle change in the activities or 
properties of certain ion channels. The exact role of iron in the modulation of these 
receptors and channels, and their downstream signaling cascade in related to the 
impaired synaptic functions, warrants further investigations. 
Since iron is well known to be a potent catalyst for the generation of ROS, the 
observed LTP suppression may be resulted from the oxidative stress elicited by the 
acute iron. We therefore tested the possible rescuing effect of anti-oxidant (ascorbic 
acid) on the iron induced LTP impairment. Ascorbic acid is a crucial anti-oxidant in 
the brain, the concentration of ascorbic acid in the brain scored the second highest 
after the adrenal gland (Lam and Daniel, 1986; Mcllwain and Bachelard, 1971). In 
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the cerebrospinal fluid, the concentration of ascorbic acid was found to be 133 士 58.8 
jimol /L (Tallaksen et al., 1992), while in the soluble cytoplasmic fraction of the rat 
brain, the concentration of this vitamin was found to be around 1.5 mM (Seregi et al., 
1978). As a competent anti-oxidant, ascorbic acid is able to inhibit the peroxidation 
of brain lipids with an IC50 of 500 jiM. Moreover, it is effective to alleviate the 
oxidative lipid damage by iron overload (Chen et al., 2000). Furthermore, 
intracellular ascorbic acid was found to elicit protective function against oxidative 
damage and NMDA-induced excitotoxicity (Qiu et al., 2007). Nevertheless, 
application of ascorbic acid at the conentrations known to be effective in reducing 
oxidative stress did not rescue the FAC-induced impairment of synaptic transmission 
and LTP. These results suggest that, in our system, the acute in vitro effect of ferric 
ion may not be mediated via the damaging effect of ROS. 
It should be noted that there are two free forms of iron, the ferrous form (Fe�.) and 
the ferric form (Fe�.). Previous studies have shown that ferrous ions can block the 
influx of Ca ions across NMDA receptor channels (Nakamichi et al., 2002; Oh and 
McCaslin, 1995). Besides, ferric ions have been discovered to block potassium 
currents on neuronal membrane (Bukanova et al., 2007). Indeed, the pro-oxidative 
activities of Fe^ "^  are five times more potent than Fe "^^ (Ying et al., 1999), and 
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therefore Fe^^ is the main transport and storage form of iron in normal biological 
system. Our experiment on the ferric ion reveals that even the less oxidative ferric 
form procurs impairment on synaptic transmission and plasticity, and oxidative stress 
may not be the explanatory mechanism. The involvement of potassium channels 
could be the potential targets for further investigations. 
4.2 Chronic, in vivo effects 
Although our in vitro experiments strongly suggest that iron can modulate the basal 
synaptic transmission and long-term synaptic plasticity in an acute manner, the 
long-term effects of iron accumulation in the intact brain may provide a more 
complete picture on the in vivo pathological conditions of neurodegenerative and 
other diseases. This is because a systematic rise of iron level has been found in 
Alzheimer disease (AD). A study has reported that the iron level in the serum 
samples of patients with AD was reported to be significantly augmented (Ozcankaya 
and Delibas, 2002). In the occasion of severe elevation of serum iron, uptake of iron 
is suggested to be facilitated through the nontransferrin-bound iron transport process, 
which leads to brain iron overloading. 
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In our in vivo model, the high dose iron treatment paradigm resulted in an increase of 
iron by around 30% (1 week paradigm) to 60% (4 weeks paradigm) in the rat 
hippocampus. This extent of iron elevation is comparable to that elicited in AD 
conditions. For instance, hippocampal iron in AD patients was found to be around 
33% higher then that of the control (AD: 288 士 20; Control 216+16 |ig/g dry weight), 
revealed by instrumental neutron activation analysis (INAA) on post mortem tissue 
(Deibel et al., 1996). Other studies using diverging measurement techniques 
manifested similar results. For example, the graphite furnace atomic absorption 
spectrometry (GFAAS) measurement on post mortem tissue (Magaki et al., 2007) 
and the quantitative MR phase-corrected imaging on AD's brain (Zhu et al., 2009) 
have both reported similar degree of elevation. 
From our experimental data, a distinctive dose-dependent but not time-dependent 
effect of our iron treatments on LTP was found. Between the course of one week and 
4 weeks period, the different in the treatment duration of both dosages of iron do not 
elicited a significant change on LTP. Nevertheless, iron accumulation either at low 
dose or high dose did affect the expression of LTP in the hippocampus, and 
interestingly, in opposite manner. While the LTP was impaired by the high dose 
treatment, its magnitude was enhanced by the low dose treatment. These data provide 
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a cellular explanation to previous behavioral and clinical studies. For instance, in 
behavioral studies, injection of ferrous ammonium citrate into honeybee brain was 
shown to suppress olfactory learning and memory (Farooqui, 2008)，while 
iron-treated rats at postnatal days 12 to 14 was found to display impairment on novel 
object recognition task at the age of 2-3 months (Perez et al.). In the rat, the iron 
chelator, desferoxamine (DFO) was found able to reverse age-related long-term 
recognition memory impairment by reducing the oxidative damage to proteins in 
cortex and hippocampus (de Lima et al., 2008). And clinically, AD patients who 
undergone DFO treatment had shown a reduced rate of cognitive decline (Crapper 
McLachlan et al., 1991). On the other hand, impairment of memory was reported in 
both experimental and clinical cases of iron deficiency (Lukowski et al.; McEchron 
et al.). 
The biphasic effect of iron on hippcampal LTP observed in our data is interestingly in 
line with the known biphasic effect of ROS on LTP (Knapp and Klann, 2002). In fact, 
we found that ROS level and protein oxidation were significantly increased by high 
dose of iron treatment while these levels were only slightly elevated in low dose 
treatment. 
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As mentioned in the introduction, iron is a potent pro-oxidative catalyst for the 
generation of ROS. Iron has been shown to facilitate protein oxidation, which could 
result in the alteration of a number of biological processes. Fe^^ ion was proven to 
bind with protein metal binding site to form a complex，which then reacts with the 
H2O2 to generate the activated oxygen species (OH, ferry 1 ion). This results in the 
modification, such as conversion to carbonyl derivatives, of the amino acid side 
chains at the metal binding site (Amici et al.，1989). The protein that undergone 
oxidation may have altered functions or becomes highly sensitive to proteolytic 
degradation. Enzymes, for instances, are susceptible to the conversion into 
catalytically inactive, less active, or more theraiolabile forms (Stadtman and Oliver, 
1991). 
Owing to its strong oxidative power, ROS can alter the properties of a plethora of 
channels, enzymes, signaling molecules as well as transcription and translation 
machinery involved in synaptic plasticity. The affected molecules that involved in 
neuronal excitability and Ca signaling ranges from voltage-gated K and Ca2+ 
channels to ryanodine receptor and calmodulin (Ciorba et al., 1997; Gao et al., 1998; 
Li et al., 1998; Ruppersberg et al., 1991; Xu et al., 1998). 
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A number of reports have proven that high concentrations of ROS impose inhibitory 
effects on synaptic transmission (Frantseva et al, 1998; Katsuki et al., 1997). For 
example, micromolar concentrations of H2O2 were found to significantly inhibit 
hippocampal-CAl LTP in guinea pig and the rat (Auerbach and Segal, 1997; Colton et 
al., 1989; Pellmaretal., 1991). 
The most notable postsynaptic molecules for LTP that is targeted by ROS are the NRl 
and NR2A subunits of NMDA receptor, both of which contain multiple 
redox-sensitive cysteine residues (Brimecombe et al., 1999; Choi et al., 2001). 
Furthermore NMDA receptor-dependent downstream signaling molecules such as 
neurogranin/RC3 (Ng), a major postsynaptic substrate for PKC after the induction of 
LTP, and calmodulin too, are the targets for ROS (Chang et al., 1997; Pak et al., 2000; 
Ramakers et al.，1995; Sheu et al., 1996; Yao et al., 1996). Congruent with NMDA 
receptor subunits, Ng harbors multiple redox-sensitive cysteine residues that can be 
oxidized by a variety of ROS agents, including NO and H2O2, to form intramolecular 
disulfides (Li et al., 1999; Pak et al., 2000). The oxidized Ng exhibit reduced affinity 
to CaM in the absence of Ca^^ and hampered its tendency to be phosphorylated by 
PKC (Chang et al., 1997; Sheu et al., 1996; Watson et al., 2002). Thus, the iron 
induced impairment of synaptic plasticity can be explained by the elevation of 
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oxidative stress which affects multiple pathways involved in LTP establishment. Of 
course, further experiments are needed to confirm or refute such hypothesis. 
Extrapolating our findings to the pathogenesis of the neurodegenerative diseases, it is 
possible that the weakening of brain's redox balance and iron regulation across the 
blood brain barrier (BBB) may impose risk for the imbalance of brain iron, which 
leads to the impairment in synaptic plasticity and thus learning and memory function. 
Although the brain contains high levels (relative to plasma) of ascorbate and citrate 
that form complexes with non-transferrin-bound iron and restrict their redox activity 
(Bradbury, 1997)，the redox balance in the brain deteriorates with age (Watson et al., 
2002). Added to that, the tight regulation of iron across the BBB is thought to 
retrogress during the course of aging, vascular diseases and repeated incidences of 
inflammatory responses (Ladewig et al., 2009; Lee et al.; Nischwitz et al., 2008). 
In addition to the disruption of the BBB, pathological surge of brain iron also occurs 
during acute circumstances, which was believed to be responsible for the aggravation 
of brain damage. Delocalization of iron has been implicated in aging, 
neurodegenerative diseases and acute brain injury, such as cerebral trauma, acidosis 
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and stroke (Bralet et al., 1992; Gutteridge et al” 1991; Komara et al., 1986; Oubidar 
et al., 1994). At the course of acute conditions (e.g. ischemia, hemorrhage, and 
trauma), iron was found to be released from the heme-containing molecules of the 
mitochondria in neurons and the ferritin in the oligodendrocytes and microglia， 
which were the suspected causes of neuronal pathology (Wagner et al., 2003). 
Moreover, in posthemorrhagic and posttraumatic brain, tissue liquefaction was 
suggested to stem from the free iron released from hemoglobin (Van Bergen et al., 
1999). Thus, the role of iron accumulation may be an important but over-looked 
factor in a number of pathological conditions in afflicting the learning and memory 
abitlity. 
In the other respect, the fact that enhancement of LTP by low dose of iron treatment, 
and the accompanying low rise in ROS level, is an intriguing finding. Although low 
level of ROS has been shown to increase LTP (Knapp and Klann, 2002), the exact 
mechanism is unknown. In fact, iron may enhance LTP via a pathway that is 
independent of ROS generation. As previously mentioned, there are evidences 
pointing to the involvement of iron in synaptic transmission. Iron is transported 
anterogradely to the synaptic terminals, probably via ferritin, and may be released 
into the synaptic cleft via ferroportin (Dwork et al., 1990; Rouault, 2001; Rouault 
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and Cooperman, 2006; Schroder, 2005; Wu et al., 2004). Owing to its functional role 
in the cellular processes, iron may increase the efficiency of enzymatic processes in 
the energy producing machinery, which facilitate the establishment of LTP via 
various kinases. Moreover, the enhanced level of iron may facilitate the enzymatic 
synthesis of neurotransmitter, which reinforces the induction of LTP. 
Interestingly, two studies have reported the increased uptake of iron resulted from in 
neuronal activation. A recent study reports that, NMDA receptor activation can leads 
to the expression of divalent metal transporter 1 (DMTl) (Haeger et al.). A separate 
study found that stimulation of NMDA receptor activates neuronal nitric oxide 
synthase and physiologically induces iron uptake via GTPase Dexrasl signaling 
cascade (Cheah et al., 2006). The requirement of iron in excitated neurons, together 
with our findings on its enhancement on LTP, has enlightened the critical function of 
iron in synaptic plasticity. 
Putting together, our studies provide the first piece of electrophysiological data to 
demonstrate the impairment of hippocampal synaptic transmission and plasticity due 
to iron overloading, and supports the notion that dys-regulation of iron can induce 
impairment in learning and memory. This set of functional evidence fills an 
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important gap for the correlation of iron accumulation and neurodegenerative 
diseases, and provides the basis for further experiments to unravel the role of iron in 
various neuropathologies. 
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